WO2008004677A1 - Liquid antimicrobial composition capable of forming transparent films - Google Patents

Liquid antimicrobial composition capable of forming transparent films Download PDF

Info

Publication number
WO2008004677A1
WO2008004677A1 PCT/JP2007/063609 JP2007063609W WO2008004677A1 WO 2008004677 A1 WO2008004677 A1 WO 2008004677A1 JP 2007063609 W JP2007063609 W JP 2007063609W WO 2008004677 A1 WO2008004677 A1 WO 2008004677A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
transparent film
forming liquid
liquid antibacterial
composition according
Prior art date
Application number
PCT/JP2007/063609
Other languages
French (fr)
Japanese (ja)
Inventor
Tetsuya Sahara
Yukiko Takahashi
Original Assignee
Nippon Soda Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Soda Co., Ltd. filed Critical Nippon Soda Co., Ltd.
Priority to JP2008523766A priority Critical patent/JP5121025B2/en
Publication of WO2008004677A1 publication Critical patent/WO2008004677A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/24Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients to enhance the sticking of the active ingredients

Definitions

  • the present invention relates to a transparent film-forming liquid antibacterial agent composition, and more particularly to a transparent film-forming antibacterial agent composition excellent in transparency and durability of antibacterial effect.
  • Patent Document 1 includes a fungicidal effect of a fungicide by adding a dialkyldimethyl ammonium salt having a carbon chain length of 10 to 14 as a water repellent film forming component in addition to a fungicide component. It is described to improve sustainability. However, the sustainability of antibacterial agents was not sufficient.
  • thiabendazole which is often used as an antifungal agent, has low solubility in solvents such as alcohol and water, so even if it is simply dissolved in an appropriate solvent and sprayed, the solution is applied immediately. It was more difficult to obtain a continuous fungicidal effect because it precipitated in the water and became cloudy. In particular, for indoor use, precipitation and white turbidity of thiabendazole gave viewers the impression that cleanliness was impaired, so there was a problem in practical use.
  • Patent Document 2 it can be applied in a short time and economically to a building exterior member in which algae 'fungi have propagated and biological contamination has progressed, and biologically contaminated parts can be easily applied.
  • a water-based anti-algae (strength) paint that can be renovated into a water-based anti-algae (strength) coating for exterior parts of buildings with synthetic resin latex as the main component, 0. 01
  • Patent Document 2 describes that the paint can be made into a transparent coating film, but this can be achieved by reducing the thickness of the resin solids concentration and reducing the film thickness (paragraph number 0 of Patent Document 2). 031).
  • the film thickness after coating is not particularly limited, and can be 0.5 to 20 ⁇ m, preferably 1 to 15 ⁇ m. Since it is thinner than ⁇ 200 / ⁇ ), the difference between the transparent coating film portion and the other portions cannot be distinguished on the coated surface according to the present invention. ”(Patent Document 2) (Refer to the description of Step No. 0040) and “The concentration of the solids in the resin is less than 1% by weight.
  • Patent Document 2 it is desirable to make the film thickness as thin as possible.
  • the film thickness is 5 m or more, if it is used for a building exterior member like the paint of Patent Document 2 (see the description in paragraph No. 0034 of Patent Document 2), the transparency is sufficient.
  • the paint of Patent Document 2 cannot provide sufficient transparency for indoor use because it will be seen closer in the case of indoor use for mirrors and tile joints.
  • Patent Document 1 Japanese Patent Laid-Open No. 10-230976
  • Patent Document 2 Japanese Patent Laid-Open No. 2003-292868
  • An object of the present invention is to provide a transparent film-forming liquid antibacterial agent composition having a high transparency and a high persistence of transparency when applied to a subject with low irritation and a high durability of the antibacterial effect. There is something to do.
  • transparent film-forming liquid antibacterial agent composition is simply referred to as “antibacterial agent composition”.
  • the present inventors use transparent organic polymer having a hydrophobic site, an antibacterial component, and an alcohol-based solvent to achieve transparency that is excellent in transparency, durability of transparency, and durability of antibacterial effect. It has been found that a film can be obtained, and the present invention has been completed.
  • the present invention relates to the following inventions.
  • a transparent film-forming liquid antibacterial agent composition comprising an organic polymer having a hydrophobic site, an antibacterial component, and water or an alcohol solvent.
  • Nonpolar basic force Alkyl group, alkenyl group, fullyl group, condensed polycyclic phenyl group, and chain polycyclic phenyl group power are selected from any one or more selected.
  • the transparent film-forming liquid antibacterial composition according to any one of (1) to (3), wherein the organic polymer further has a hydrophilic site.
  • the transparent film formation according to (5) characterized in that it is one or two or more selected from the group force consisting of an acid group, a carboxylic acid group, an aluminate group, a nitrile group, and a thioalcohol group Liquid antibacterial composition.
  • Antifungal ingredients are thiabendazole, 3 odor-2 propargyl butyl carbamate, 1, 2 benzotriazoline 1-one, jodomethyl 1-p-tolylsulfone, 2, 3, 5, 6 (Methylsulfuryl) pyridine, and 1— (2- (2,4 Diclonal Methyl) 2- (2-Probeoxy) ethyl) 1H-imidazole (imazalyl) Power Group force selected Any 1 The transparent film-forming liquid antibacterial composition according to (11), wherein the composition is a seed or two or more kinds.
  • the transparent film-forming liquid antibacterial agent composition according to any one of (1) to (21), a transparent film-forming liquid antibacterial agent composition for windows, a transparent film-forming liquid antibacterial agent composition for kitchens, and a bathroom A method for use as a transparent film-forming liquid antibacterial agent composition.
  • a spray-type antibacterial agent wherein the transparent film-forming liquid antibacterial agent composition according to any one of (1) to (21) is contained in a container.
  • FIG. 1 is a diagram showing a 13 C-NMR chart of a styrene maleic anhydride copolymer (resin A).
  • FIG. 2 is a diagram showing a 13 C-NMR chart of styrene-maleic anhydride copolymer hydrolyzate (resin a).
  • FIG. 3 is a diagram showing IR ⁇ vector of rosin A.
  • FIG. 4 is a diagram showing the IR ⁇ vector of rosin a.
  • FIG. 5 is a diagram showing IR ⁇ vector of rosin B.
  • FIG. 6 is a diagram showing an IR ⁇ vector of rosin b.
  • FIG. 7 is a diagram showing IR ⁇ vector of rosin C.
  • FIG. 8 is a diagram showing the IR ⁇ vector of rosin c.
  • FIG. 9 is a diagram showing IR ⁇ vector of rosin D.
  • FIG. 10 is a diagram showing an IR ⁇ vector of rosin d.
  • FIG. 11 is a diagram showing an IR spectrum of rosin E.
  • FIG. 12 is a diagram showing IR ⁇ vector of rosin e.
  • FIG. 13 is a diagram showing IR ⁇ vector of rosin F.
  • FIG. 14 is a diagram showing the IR ⁇ vector of rosin f.
  • FIG. 15 is a diagram showing IR ⁇ vector of rosin G.
  • FIG. 16 shows an IR spectrum of rosin g.
  • the antibacterial agent composition of the present invention is not particularly limited as long as it contains an organic polymer having a hydrophobic site, an antibacterial component, and an alcohol solvent.
  • the organic polymer refers to an organic polymer having a hydrophobic site.
  • the hydrophobic site is not particularly limited, but examples thereof include alkyl groups; vinyl groups, vinylidene groups, alkenyl groups such as ethynyl groups; condensed polycyclic phenols such as phenyl groups, naphthyl groups, and anthral groups.
  • alkyl groups vinyl groups, vinylidene groups, alkenyl groups such as ethynyl groups
  • condensed polycyclic phenols such as phenyl groups, naphthyl groups, and anthral groups.
  • the following can be listed: a ru group; a chain polycyclic fur group such as a biphenyl group and a terfenyl group; and other nonpolar groups.
  • the organic polymer used in the present invention may not have a hydrophilic site, but from the viewpoint of superior transparency, durability of transparency, and durability of antibacterial effect, the hydrophilic polymer is further. It is preferable to have.
  • the hydrophilic site is not particularly limited, and examples thereof include a carboxyl group and a metal salt or an amine salt thereof; a sulfonic acid group and a metal salt or an amine salt thereof; a sulfoamide group; an amide group; an amino group; an imino group; a hydroxy group; Amino group; oxiamino group; diazo-um group; guanidine group; hydrazine group; phosphoric acid group; carboxylic acid group; aluminate group; -tolyl group; thioalcohol group; Among them, carboxyl group, sulfonic acid group, sulfoamide group, amide group, amino group, imino group, hydroxy group, quaternary amino group, oxyamino group, diazonium group, guanidine group, hydrazine group, phosphoric acid group, and caiic acid group , Aluminate group, nitrile group, and thioal
  • the organic polymer used in the present invention is a monomer having a hydrophilic portion. And a copolymer of one and a monomer having a hydrophobic part, and a polymer of a monomer having a hydrophilic part and a hydrophobic part.
  • a copolymer of a monomer having a hydrophilic part and a monomer having a hydrophobic part is: Preferred is a random copolymer of both monomers.
  • Examples of the monomer having a hydrophilic portion include mono- or dicarboxylic acid monomers such as acrylic acid, methacrylic acid, maleic acid, and itaconic acid, 2-atallylooxychetyl-2-hydroxyethyl phthalic acid, Monomers containing hydroxyl groups such as 2-hydroxy-3-phenoxypropyl acrylate, 2-hydroxyethyl methacrylate, N-methylol acrylamide, monomers containing sulfonic groups such as sodium styrenesulfonate and sulfonated isoprene, acrylamide, methacryl Examples include amide compound monomers such as amides.
  • mono- or dicarboxylic acid monomers such as acrylic acid, methacrylic acid, maleic acid, and itaconic acid can be preferably exemplified, and dicarboxylic acid monomers such as maleic acid and itaconic acid. More preferred It can be mentioned.
  • the monomer having a hydrophilic moiety used in the present invention may or may not have a hydrophilic moiety in the monomer state, and has a hydrophilic moiety in the state of the organic polymer contained in the antibacterial agent composition. It only has to be.
  • a maleic anhydride monomer does not have a hydrophilic site, but in the state of an organic polymer contained in the antibacterial agent composition, the anhydride group of maleic anhydride is opened by hydrolysis, resulting in a hydrophilic site. If a carboxyl group is generated, it is considered as an organic polymer having a hydrophilic portion.
  • a dicarboxylic acid monomer such as maleic acid or itaconic acid
  • Monomers having a hydrophobic site include, for example, methyl (meth) acrylate, ethyl (meth) acrylate, (iso) propyl (meth) acrylate, (iso or tertiary) butyl (meth) acrylate.
  • Examples of the monomer having a hydrophilic part and a hydrophobic part include N-ethyl (meth) acrylamide, N-cyclopropyl (meth) acrylamide, N-isopropyl (meth) atrylamide, N-n-propyl ( (Meth) acrylamide, N-methyl-N-ethyl (meth) atrylamide, N, N-jetyl (meth) acrylamide, N-methyl-N-isopropyl (meth) acrylamide, N-methyl-N-n-propyl (meth) Acrylamide, N-Buylpyrrolidone, N-Vinylcaprolatatam, N-Isopropenylpyrrolidone, N-Isopropenylcap latatam, N- (Meth) atalyloylpyrrolidine, N- (Meth) atalyloylbiperidine I can list them.
  • the organic polymer used in the present invention include styrene maleic acid copolymers and derivatives thereof.
  • styrene maleic acid copolymer a compound having a ratio of styrene: maleic acid of 3: 1 to 1: 1 is preferably used, more preferably a compound of 2: 1, and particularly preferably a compound of 1: 1.
  • the styrene maleic acid copolymer derivative means a compound capable of inducing styrene maleic acid copolymer force and can be used in the present invention in the same manner as the styrene maleic acid copolymer.
  • the acid anhydride group of the maleic anhydride moiety is ring-opened to form a monoester Z monocarboxylic acid group or a styrene maleic acid copolymer.
  • a copolymer having a substituent such as a sulfonyl group at an appropriate position of the aromatic group a copolymer in which the maleic anhydride portion of the styrene maleic anhydride copolymer is imidized with amine, or a styrene maleic anhydride
  • examples include an ester group formed by ring opening of an acid anhydride group or a copolymer in which a carboxylic acid group is imidized with an amine.
  • a styrene maleic acid copolymer type (TG-750W: manufactured by Kyoeisha Co., Ltd.) (a maleic anhydride maleic anhydride polymer)
  • the acid anhydride group of the inic acid moiety is opened to form a monoester Z monocarboxylic acid group, a copolymer), SMA ester resin (manufactured by Sartoma Co., Ltd.) (styrene maleic anhydride polymer maleic anhydride) Copolymers in which the acid anhydride group of the acid moiety is opened to form a monoester Z monocarboxylic acid group), SMA resin: Ammonium salt aqueous solution (manufactured by Sartoma Co., Ltd.)
  • Preferred examples include copolymers in which the acid anhydride group of the maleic anhydride portion of the polymer is hydrolyzed to form a dicarboxylic acid group.
  • the molecular weight of the organic polymer is not particularly limited as long as the effects of the present invention can be obtained.
  • the number average molecular weight is preferably in the range of 1,000 to 100,000, and in the range of 2,000 to 20,000. More preferably, it is within.
  • the solubility of the organic polymer in water is preferably 5 to 5000 ppm, more preferably 10 to 20 OOppm! /.
  • the solubility of at least one organic polymer is 5 to 5000 ppm. More preferably, the weight percentage of the whole organic polymer is 30% or more.
  • Examples of the antibacterial component used in the present invention include known antifungal components, antibacterial components, antiyeast components, antiviral components, and the like.
  • the solubility in water is 0.2 g or less
  • the antibacterial component which has a solubility in a diol of 0.2 g or more, preferably 0.5 g or more and is solid at room temperature can be used after being dissolved.
  • solubility of antibacterial components in water and “solubility of antibacterial components in ethanol” refer to solubility in 100 g of water at 20 ° C and solubility in 100 g of ethanol at 20 ° C, respectively.
  • An antibacterial component having a solubility in water of not more than 0.2 gZl00 g and a solubility in ethanol of not less than 0.2 gZl00 g is more compatible with the organic polymer used in the present invention and can provide a highly transparent coating film. .
  • a fungicide component can be particularly preferably exemplified.
  • Antifungal agents that can be dissolved and used include thiabendazole (TBZ), 3- ododo 2-propargyl butyl carbamate, 1, 2-benzotriazolin-3-one.
  • antibacterial 'anti-yeast components 2, 4, 4' trichloro-2 'hydrated oxydiphenyl ether, 1, 2 benzothiazolone 3, N- (fluorochloromethylthio) phthalimide, 2, 4, 5, Specific examples thereof include 6-tetrachloro-isophthalonitrile and 1,3 bis (hydroxymethyl) -1,5'-dimethylhydantoin.
  • the solvent used in the present invention is preferably a strong alcohol solvent that is water or an alcohol solvent.
  • the alcohol-based solvent is not particularly limited as long as it is 100% alcohol or aqueous alcohol,. 20 to: L00 that hydroalcoholic containing alcohol weight 0/0 is good Mashigu 30-70 wt 0/0 it is water-containing alcohol containing alcohol more preferably a hydrous alcohol containing more preferred instrument 40-60 wt 0/0 alcohol. Further, the alcohol in the alcohol solvent may be one kind alone or may contain two or more kinds of alcohols. Ethanol is preferred as the alcohol in the alcohol solvent.
  • the antibacterial agent composition of the present invention is a film having a thickness of 20 to 300 nm formed by spray coating on a salted glass substrate, and the haze ratio after 24 hours from coating is preferably 5.0 or less, preferably 3.
  • An antibacterial agent composition having an organic polymer, an antibacterial component, and an alcohol-based solvent that is 3.0 or less, more preferably 2.0 or less.
  • the haze ratio in this specification was spray-coated on a 0.5 mm thick transparent salty vinyl sheet (manufactured by Atari Sunday, transparent rigid vinyl chloride board, haze ratio: 1.0 to 1.3). This is the value measured with a device made by Nippon Denshoku Industries Co., Ltd. after the coating film was dried at room temperature for 24 hours. If the haze ratio of the formed coating film is 5.0 or more, the coated surface is colored white and the aesthetic appearance is impaired. When such a coating film comes into contact with water, antibacterial components are eluted at an early stage. The effective period for maintaining the antibacterial effect is shortened.
  • the haze ratio is high.
  • the coating film is magnified and observed with a microscope, the antibacterial agent crystals are scattered as protrusions in the smooth coating film.
  • the coating film in which the sample is immersed in water for a certain period of time is used. It turns out that the crystal
  • the haze ratio is low, the coating film has a high haze ratio, and even if the ratio of the resin and the antibacterial agent is the same as that of the coating film, no antibacterial crystals are observed. The effect lasts for a long time.
  • the haze ratio is low, and the coating film has good compatibility between the resin and the antibacterial agent, so that the antibacterial agent is not separated and crystallized, and the resin and the antibacterial agent are uniformly dissolved.
  • the antibacterial effect lasts for a long time, but in the coating film with a high haze rate, the antibacterial agent and antibacterial agent are separated and the antibacterial agent forms a protruding crystal.
  • the crystallized antibacterial agent elutes early, and the concentration of the active ingredient in the coating film decreases, and the effective period of the antibacterial effect of the coating film is estimated to be shortened.
  • the content of the organic polymer in the antibacterial agent composition of the present invention is such that a 50% ethanol aqueous solution containing the organic polymer and 0.1% by weight of an antibacterial component is spray-coated on a vinyl chloride substrate.
  • the film having a thickness of 5 to 500 nm is not particularly limited as long as the haze ratio after 24 hours from application is 5.0 or less, but is 0.01 to 10% by weight with respect to the total amount of the antibacterial agent composition. More preferably, it can be in the range of 0.1 to 5% by weight, still more preferably 0.2 to 3% by weight, and more preferably 0.3 to 1% by weight.
  • the content ratio of the antibacterial component in the antibacterial agent composition of the present invention is such that a 50% ethanol aqueous solution containing the antibacterial component and 0.3% by weight of the organic polymer is sprayed onto a bull chloride substrate.
  • the haze ratio after coating for a film of 5 to 500 nm thickness formed after coating is 5.0 or less, but it is 0.01 to 10 weight with respect to the total amount of the antibacterial agent composition.
  • % More preferably 0.03 to 5% by weight, still more preferably 0.07 to 3% by weight, and even more preferably 0.1 to 1% by weight.
  • the above range of the content ratio of the antibacterial component is similarly applied when the antibacterial component is the above-described specific antibacterial component such as thiabendazole.
  • the mixing ratio of the organic polymer and the antibacterial component in the antibacterial agent composition of the present invention is such that a 50% ethanol aqueous solution containing the organic polymer and the antibacterial component is spray-applied to a vinyl chloride substrate.
  • the thickness ratio of the organic polymer to the antibacterial component is 1:50 to 50, as long as the haze ratio after coating for a film having a thickness of 5 to 500 nm is 5.0 or less. 1, more preferably 1:10 to: L0: 1, still more preferably 2: 1 to 5: 1, more preferably 2.5: 1 to 3.5: 1.
  • the antibacterial agent composition of the present invention has a haze ratio of 5.0 to 24 hours after application of a 5 to 500 nm thick film formed by spray-coating the antibacterial agent composition onto a salted glass substrate.
  • an optional component may be included in addition to the organic polymer having a hydrophobic site, the antibacterial component, and the alcohol solvent.
  • optional components include dispersion stabilizers, surfactants, water repellent components, organometallic compounds, amphiphilic metal oxide nanoparticles, and the like.
  • the antibacterial composition can be dissolved and dispersed more uniformly, which contributes to the sustainability of transparency and the sustainability of the antibacterial effect.
  • it further contains amphiphilic metal oxide nanoparticles when the antibacterial agent composition of the present invention is sprayed on a target, it has better transparency, transparency persistence, and antibacterial properties. Sustained effect is obtained.
  • the dispersion stabilizer refers to an agent such as a deflocculating agent, an anticoagulant such as a protective colloid having the effect of stably dispersing the dispersoid in the dispersion medium, such as glycolic acid, darconic acid, Polycarboxylic acids such as lactic acid, tartaric acid, citrate, malic acid and succinic acid; hydroxycarboxylic acids; phosphoric acids such as pyrophosphoric acid and tripolyphosphoric acid; acetylacetone, methyl acetoacetate, ethyl acetoacetate, n-propyl acetoacetate, Isopropyl acetate, n-butyl acetate, sec butyl acetate, t-butyl acetate, 2,4 hexanedione, 2,4 heptanedione, 3,5 heptanedione, 2,4 octanedione, 2,4 nonanedi
  • surfactant examples include surfactants such as an anionic surfactant, a cationic surfactant, an amphoteric surfactant, and a nonionic surfactant.
  • anionic surfactants include alkyl sulfates, polyoxyethylene alkyl ether sulfates, sulfosuccinates, amide ether sulfite types, sarcosine derivatives, phosphate ester types, stone wall types, and sulfonic acid types. Examples thereof include ionic surfactants.
  • cationic surfactant examples include cationic surfactants such as alkyl trimethyl ammonium salt, alkylamide amine type, alkyl dimethyl benzyl ammonium salt, and cationized polymer.
  • Nonionic surfactants include alkyl amide type: pegnol L 4, pegnol TH-8, pegnol L-9A, pegnol L 12S, pegnol L-20S, pegnol T-6, pegnol T-6 Gunol TE-10A, Pegnol ST-7, Pegnol ST-9, Pegnol ST-12, Pegnol 0-6A, Pegnol 0-107, Pegnol 0-16A, Pegnol 0-20, Pegnol Polyoxyethylene alkyls such as 0-24, Pegnol C-18, Pegnol S-4D, Pegnol HC-10 (manufactured by Toho Chemical Industry Co., Ltd.), Emargen 705, Emargen 707, Emargen 709 (manufactured by Kao Corporation) Ether
  • the water-repellent components include MegaFuck F-475 (Dainippon Ink Co., Ltd.), MegaFuck F-480SF (Dainippon Ink Co., Ltd.), MegaFuck F-470 (Dainippon Inkki).
  • Fluorine-based surfactants such as MegaFuck F-482 (Dainippon Ink Co., Ltd.), Dickguard F-90N (Dainippon Ink Co., Ltd.), Dickguard TE-5A (Dainippon) Fluorine fiber processing agents such as Ink Co., Ltd. and Dickguard F-445 (Dainippon Ink Co., Ltd.) can be suitably exemplified.
  • Preferable examples include methylpolysiloxane, dimethylsilicone oil, methylhydrogen silicone oil, modified silicone oil, and their emulsions.
  • organometallic compound examples include organometallic compounds containing, for example, titanium, zirconium oxide, aluminum, and silicon.
  • tetraisopropyl titanate, tetranormal butyl titanate, butynoretitanate dimer, tetra (2-ethylhexyl) titanate, tetramethinoretitanate, titanium acetylacetonate, titanium tetraacetyl acetate, Titanium ethyl acetate, titanium octanediolate, dihydroxybis (ammonium lactate) Titanium, titanium ratatoate, titanium triethanolamate, polyhydroxytitanium stearate, etc. can be preferably exemplified.
  • Particularly preferred are hydrophilic organometallic compounds such as titanium lactate.
  • amphiphilic metal oxide nanoparticles are not particularly limited as long as they have an affinity for both an aqueous solvent and an organic solvent, for example, hydrolysis. Examples thereof include hydrolysis products of metal compounds having a total of 2 or more functional groups and Z or hydroxyl groups, hydrolysis products of metal chelate compounds having 1 or more of total hydrolyzable groups and Z or hydroxyl groups, and the like.
  • amphiphilic metal oxide nanoparticles are added to the antibacterial agent composition of the present invention, when the film is formed using the composition, the hydrophobicity of the film is improved, and as a result, the water resistance of the film is improved. It is thought to improve.
  • the metal compound having two or more hydrolyzable groups and Z or hydroxyl groups in total is a metal compound having two or more hydrolyzable groups and Z or hydroxyl groups in total.
  • the hydrolyzable group is a functional group that hydrolyzes upon contact with water, or A functional group that can form a bond through a metal atom and an oxygen atom in the presence of water, specifically, a halogen atom, an amino group, an alkoxy group, an ester group, a carboxy group, a phosphoryl group, an isocyanate group. , Cyan group, epoxy group and the like.
  • the compound represented by Formula (I) can be illustrated preferably.
  • M represents a metal atom, preferably a metal atom of Group 13 to Group 15 of the periodic table, and more specifically, silicon, germanium, tin, lead, Titanium, zirconium, aluminum, indium, tantalum, tungsten, zinc, etc. can be exemplified, and among these, silicon, germanium, titanium, zirconium, and aluminum are more preferable.
  • R represents a hydrogen atom or an organic group which may have a hydrolyzable group capable of forming a bond via a metal atom and an oxygen atom.
  • the organic group that can be used include an alkyl group, an alkenyl group, and an aromatic group.
  • the carbon number of the organic group is not particularly limited, but is usually 1 to 20, preferably 1 to 12.
  • Specific examples of R include alkyl groups such as methyl, ethyl and propyl; chloromethyl, chloroethyl, chloropropyl, bromopropyl, bromooctyl and trifluoropropyl groups.
  • Halogenated alkyl groups such as: glycidoxypropyl group, epoxycyclohexyl group such as epoxycyclohexyl group; aminoalkyl groups such as aminoamino group, aminobutyl group; alkenyl groups such as buryl group, aryl group, etc .; And (meth) acryloxyalkyl groups such as xylpropyl group and methacryloxypropyl group; aralkyl groups such as benzyl group; aromatic groups such as phenyl group and naphthyl group;
  • X represents a hydrolyzable group or hydroxyl group bonded to M.
  • alkoxy having 1 to 12 carbon atoms such as methoxy group, ethoxy group, n-propoxy group, isopropoxy group, n-butoxy group, sec-butoxy group, t-butoxy group, n-pentyloxy group, etc.
  • a group containing a nitrogen atom such as a hydroxyimino group, a hydroxyamino group, an enoxy group, an amino group, or a strong rubamoyl group; a halogen atom such as a chlorine atom or a bromine atom; a hydroxyl group; Monkey.
  • Germanium alkoxides titanium alcohols such as tetra-n-propoxy titanium, tetra-isopropoxy titanium, tetra-n-butoxy titanium, tetra-sec butoxy titanium, tetra-butoxy titanium
  • Zirconium alkoxides such as tetra-n-propoxyzirconium, tetraisopropoxyzirconium, tetra-n-butoxyzirconium, tetra-sec butoxyzirconium, tetra-t-butoxyzirconium; triethoxyaluminum, tri- n -propoxyaluminum , Triisopropoxyaluminum, tri-n-butoxyaluminum, trisec butoxyaluminum, tri-butoxyaluminum and other aluminum alkoxides; tetrachlorosilane, tetrabromosilane, dimethyldichlorosilane, benzyltrichlorosi
  • silane compounds such as butylmethylbis (methylethylketoximine) silane; 3, 3, 3-trifluoropropyl methoxydimethoxyhydroxysilane, 3, 3, 3-trifluoropropylmethoxydihydroxysilane, otachinole And hydroxysilanes such as ethoxydihydroxysilane.
  • metal alkoxides such as silane alkoxide, germanium alkoxide, titanium alkoxide, zirconium alkoxide, and aluminum alkoxide are preferable, and silane alkoxide, titanium alkoxide, and zirconium alkoxide are more preferable.
  • the above-mentioned metal chelate compound having one or more hydrolyzable groups and one or more Z or hydroxyl groups has one or more hydrolyzable groups and one or more Z or hydroxyl groups, and the chelate compound is bonded.
  • the hydrolyzable group is not particularly limited as long as it can be hydrolyzed to produce amphiphilic metal oxide nanoparticles. Examples of the hydrolyzable group include the hydrolyzable group and In the case of metal compounds having a total of two or more Z or hydroxyl groups, the same examples can be mentioned.
  • Examples of chelate compounds include j8-ketoesters such as methyl acetoacetate, ethyl acetoacetate, acetoacetate n-propyl, acetoacetate isopropyl, acetoacetate-n-butyl, acetoacetate-sec butyl, acetoacetate tbutyl Acetylacetone, hexane 2,4-dione, heptane 2,4 dione, heptane 3,5 dione, octane 2,4 dione, nonane 1,2,4 dione, 5-methyl-hexane 1,2,4 dione, etc.
  • j8-ketoesters such as methyl acetoacetate, ethyl acetoacetate, acetoacetate n-propyl, acetoacetate isopropyl, acetoacetate-n-butyl, acetoacetate-sec butyl, acetoacetate tbutyl Acety
  • J8-diketons oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid and other saturated aliphatic dicarboxylic acids; ethylene glycol and other glycols; oxyacetic acid Glycolic acids such as ethylenediamine tetraacetic acid (EDTA) and its sodium salt, ethylenediamine, 1,3 propanediamin, diethyl Nitrogen-containing compounds such as lentriamin, pentamethyljetylenetriamine, hexamethyltriethylenetetramine, tris [2- (dimethylamino) ethyl] amine, tri (pyridyl-methyl) amine; , Nicotinic acid, isonicotinic acid, phenanthorin, diphenantorin, substituted phenantorin, 2, 2 ', 6', 2, monoterpyridine, pyridineimine
  • a metal chelate compound having a total of 1 or more hydrolyzable group and Z or hydroxyl group diethoxybisacetinoreacetonate titanium, diisopropoxybisacetinoreacetonate titanium, dinormalpropoxybisacetylene Setonate Titanium, Dinormal Butoxy Bisacetylacetonate Titanium, Diethoxybisacetyl Casetonate Zirconium, Diisopropoxybiscetinoreacetonate Zinoreconium, Dinoremanole Propoxybis Acetylacetonate Zirconium, Di-N-Butoxybisacetyl cetate tozyl corn, Jetoxy cetinoreacetonato anoreminium, Diisopropoxy cetinorea Setonate Aluminum, Di-N-propoxy cetylacetonate Aluminum, Dinormal Butoxyacetyl acetonate aluminum, ethoxy bis (acetyl cetate) aluminum, isopropoxy bis (acetyl cetton
  • the metal chelate compound having one or more hydrolyzable groups and Z or hydroxyl groups in total includes, for example, a predetermined amount of a chelate compound in a metal compound having one or more hydrolyzable groups and Z or hydroxyl groups in total. It can obtain by adding and stirring. The resulting metal-cleared toy compound can be isolated, but can be used in the subsequent hydrolysis and polycondensation reaction as it is.
  • the hydrolysis product is a group consisting of a metal compound having a total of 2 or more hydrolyzable groups and Z or hydroxyl groups, and a metal chelate compound having a total of 1 or more hydrolyzable groups and Z or hydroxyl groups.
  • Hydrolysis with 1 mol or more, preferably 5 mol or more, more preferably 10 mol or more of water with respect to 1 mol of at least one selected (hereinafter collectively referred to as “metal compound etc.”).
  • the hydrolysis product may be a complete hydrolysis product or a partial hydrolysis product.
  • a hydrolysis product of a metal chelate compound having a total of 1 or more hydrolyzable groups and Z or hydroxyl groups is particularly preferred.
  • a metal chelate compound is dropped into water and hydrolyzed and mixed with an alcohol solution of an antibacterial component to obtain an antifungal solution, and 2) a metal chelate compound is added to an alcohol solvent. Then, water is added to hydrolyze, and then mixed with the alcohol solution of the antibacterial component to obtain an antifungal solution.
  • the method described in 3) is particularly preferred, and the preparation is preferably carried out at 0 ° C to room temperature.
  • an alcohol solvent such as ethanol or propanol is preferable.
  • an acid, a base and Z or a dispersion stabilizer may be added when hydrolyzing with water or after hydrolysis.
  • acids to be added include mineral acids such as hydrochloric acid, nitric acid, boric acid and borohydrofluoric acid, organic acids such as acetic acid, formic acid, oxalic acid, carbonic acid, trifluoroacetic acid, p-toluenesulfonic acid and methanesulfonic acid.
  • a photoacid generator that generates an acid upon irradiation with light such as diphenyl-sulfo-hexoxano-reno-oral phosphate and triphenylenophospho-hexafluorophosphate; Examples include triethanolamine, triethylamine, 1,8-diazabicyclo [5.4.0] -7-undecene, ammonia, dimethylformamide, and phosphine.
  • the particle size of the amphiphilic metal oxide nanoparticles is 0.8 ⁇ ! ⁇ 100nm, preferably 1 ⁇ ! ⁇ 30nm, more preferably 3 ⁇ ! -LOnm nanoparticle strength Excellent dispersibility, can form a thin film with a thickness of 20-50 nm, and when used in combination with antibacterial components, forms a uniform mixture with antibacterial components, etc. Is preferable in that it precipitates as fine particles and does not precipitate into large crystals.
  • the amphiphilic metal oxide nanoparticles are preferable in that they can form nanoparticles with a uniform particle size of amphiphilic acid titanium nanoparticles.
  • the content of the metal oxide nanoparticles is 0.01 to 10 with respect to the total amount of the antibacterial agent composition. % By weight, particularly 0.1 to 2% by weight, is preferable for forming a transparent and flexible thin film.
  • the content of the antibacterial component is the content of metal oxide nanoparticles such as titanium oxide nanoparticles. (Weight) is 0.01-5 times, especially 0.1-2 times, such as antibacterial components and acid titanium nanoparticles It is preferable at the point which can form a uniform mixture with a metal oxide nanoparticle.
  • the antibacterial agent composition of the present invention is used for rubber packing of windows; ceilings in bathrooms, wall surfaces, drain outlets, tile joints; washstands; If it is the method of apply
  • the antibacterial agent composition of the present invention is a composition containing a antibacterial agent as an active ingredient, the rubber packing of the window; the ceiling of the bathroom, the wall surface, the vicinity of the drainage, the joint of the tile; It is used for the purpose of preventing the occurrence of mold by applying it to the place where it tends to grow.
  • a composition containing an antibacterial 'anti-yeast agent' as an active ingredient it is applied to the toilet floor and walls and the inner and outer wall surfaces of the toilet to prevent the scattered urine from decaying and generating odors.
  • it can be applied to the floor around the garbage collection area to prevent the liquid flowing out from the garbage from decaying and producing odors. It is used for the purpose of
  • the spray spraying method is preferable.
  • the thickness of the film formed by the antibacterial agent composition of the present invention is not particularly limited, but can be preferably in the range of 5 to 500 nm, more preferably in the range of 20 to 300 nm.
  • the spray-type antibacterial agent of the present invention is not particularly limited as long as the antibacterial agent composition of the present invention is contained in a container, and the container is not particularly limited as long as it can spray contents. Not limited to.
  • the reaction was performed at ° C for 6 hours.
  • the reaction solution was allowed to cool, reprecipitated with THF-methanol solvent, and dried to obtain 39.03 g of a styrene maleic anhydride copolymer.
  • the recovery rate was 87%.
  • the molecular weight of the obtained polymer was measured by GPC.
  • GPC used THF as a solvent and polystyrene as a standard substance. As a result, the number average molecular weight was 11,000, the weight average molecular weight was 82000, and the main peak was 19000. This rosin is hereinafter referred to as “Resin A”.
  • the fat A and the fat a obtained in the above (1) and (2) were analyzed by 13 C-NMR (single pulse decoupled without NOE method). It was confirmed that the copolymer yarn ratio of styrene and maleic anhydride in a was 1: 1, and that there was no unreacted maleic anhydride site in resin a.
  • Fig. 1 shows the 13 C-NMR chart of rosin A
  • Fig. 2 shows the 13 C-NMR chart of rosin a
  • Figure 3 shows the IR ⁇ vector of rosin A
  • Figure 4 shows the IR ⁇ vector of rosin a.
  • compositions having the compositions shown in Examples 1-2 and Comparative Example 1 in Table 1 below were prepared.
  • the compositions shown in Examples 1-2 and Comparative Example 1 were prepared by adding and mixing components other than the ethanol aqueous solution in the ethanol aqueous solution and stirring for 30 minutes or more.
  • a commercial product from AP was used for Comparative Example 1.
  • PAA Polyacrylic acid
  • a vinyl chloride substrate (made by Atari Sunday, transparent hard vinyl chloride plate, thickness 0.5mm, haze ratio 1.0 to 1.3) is prepared, and a bar coater (automatic coating equipment PI-1210 and ROD The composition of Example 1 was applied onto the vinyl chloride substrate using No. 5 bar (manufactured by Tester Sangyo Co., Ltd.). Various evaluations were performed using the samples formed by drying at room temperature for 24 hours after coating as film formation samples.
  • Example 2 The same operation was carried out using the composition of Example 2 and Comparative Example 1 in place of the composition of Example 1, and a film-forming sample was obtained for each.
  • Mold prevention test A film sample obtained by the same method as in 2 above was cut into a size of 3 cm ⁇ 7.5 cm to obtain a test piece. 50 ml of ion exchange water was put into the petri dish, and the test piece was immersed in the petri dish for a predetermined time (0, 1, 5, 10, 20, 40, 60 minutes) shown in Table 3. After soaking, it was dried at room temperature for 24 hours. Then, the presence or absence of mold on the surface of the test piece was evaluated in four stages. The results are shown in Table 3.
  • a contact angle was measured using water droplets.
  • the contact angle was measured with a contact angle meter (“Drop Master 700” manufactured by Kyowa Interface Science Co., Ltd.).
  • Table 4 shows the measured contact angles for each film sample. From this result, it was found that the film forming sample strength with a 3: 1 ratio of resin a: TBZ showed the highest hydrophobicity.
  • the contact angle of the salt-metal substrate as a blank was measured and found to be 65.8 °.
  • the number of carboxyl groups of rosin a is excessive with respect to TBZ1 molecules (TBZ1 with respect to carboxylic group 6 in molar ratio) even if rosin a: TBZ 3: 1. It is considered that this excess carboxyl group contributes to hydrophilization as the addition amount of is increased.
  • Resin B 2800 4500 4400 1/1 Resin C 2800 5000 4800 1/1 Resin D 4300 10000 8800 1/1 Resin E 23000 1 34000 53000 1/1 Resin F 30000 217000 58000 1/1 Resin G 3200 5900 5500 2/1
  • Commercially available resins B to G were hydrolyzed in the same manner as in Example A to obtain styrene maleic acid copolymers. The progress of hydrolysis was confirmed by IR spectrum. Table 6 shows the charge, yield, and yield of each. Each IR spectrum is shown in Figs.
  • compositions having the compositions shown in Examples 3 to 12 and Comparative Examples 2 and 3 in Table 7 below were prepared. The production method was carried out in the same manner as in Example A, and it was again prepared in Example 2.
  • composition of each example and comparative example is water.
  • Example 3 to 12 Samples of Examples 3 to 12, Example 2, and Comparative Examples 2 and 3 were prepared from a salty vinyl substrate (manufactured by Akrisande, transparent rigid vinyl chloride plate, thickness 0.5 mm, haze ratio 1.0 to 1). 3) was prepared, and the bull chloride substrate was placed vertically on the ground and applied with a commercially available spray bottle from a distance of 20 cm. Various types of evaluations were performed using samples formed by drying at room temperature for 24 hours after coating, as film formation samples.
  • a salty vinyl substrate manufactured by Akrisande, transparent rigid vinyl chloride plate, thickness 0.5 mm, haze ratio 1.0 to 1).
  • Table 8 shows the results of measuring the haze ratio of the above samples using a turbidimeter (manufactured by Nippon Denshoku Industries Co., Ltd.).
  • a film sample obtained by the above method was cut into a size of 3 ⁇ 7.5 cm to obtain a test piece.
  • 20 mL of ion-exchanged water was put in the petri dish, and the test piece was immersed in the petri dish for a predetermined time described in Table 9.
  • the test piece was taken out every 2 hours and ion-exchanged water was exchanged. After immersion, it was dried at room temperature for 24 hours. Thereafter, a 3 ⁇ 3 cm cut sample was placed on an agar medium, and a black mold fungal spore suspension was spray-coated, and the presence or absence of force on the surface of the test piece was evaluated in four stages.
  • Example 1 2 Satoshi Satoshi Satoshi Comparative Example 2 ⁇ ⁇ + + + + + + + + + Comparative Example 3 ⁇ Ten + + + + +
  • Molds were grown on the entire surface, and the actual mold-proofing performance was evaluated in bathrooms with water-borne paint walls.
  • Test place Water-based paint wall bathroom (Niigata Prefecture)
  • Mold was removed from the wall surface of the water-borne paint, which was moldy, with a sodium hypochlorite mold remover. Showered and dried for 1 hour. The drug was then sprayed into the following four compartments. The size of one section is vertical lmX horizontal 0.5m. Dry for 3 hours. After that, using the bathroom as usual, we observed the occurrence of mold. The results are shown in Table 11. Sample No. 1 Blank... As it is, without applying a protective agent
  • 2, 4, 4, 1-trichloro-2, 1-hydroxydiphenyl ether and 1,2-benzothiazolone 3 are antibacterial and anti-yeast components.
  • compositions of Examples 13 and 14 were formed by the same method as Example B.
  • the haze ratio was measured by the same method as in Example B. Table 12 shows the measurement results.
  • the antibacterial agent composition of the present invention has high transparency and transparency when applied to a subject with low irritation and high antibacterial effect.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paints Or Removers (AREA)

Abstract

The invention aims at providing a liquid antimicrobial composition which is lowly irritant and which can give a transparent film exhibiting high transparency, high persistency of transparency and high persistency of antimicrobial activity when sprayed an object of treatment. The composition is characterized by comprising an organic polymer having a hydrophobic moiety, an antimicrobial component, and water or an alcoholic solvent. The hydrophobic moiety is preferably a non-polar group, more specifically, one or more members selected from the group consisting of alkyl, alkenyl, phenyl, fused polycyclic phenyl and chain polycyclic phenyl.

Description

明 細 書  Specification
透明膜形成液状抗菌剤組成物  Transparent film-forming liquid antibacterial agent composition
技術分野  Technical field
[0001] 本発明は、透明膜形成液状抗菌剤組成物に関し、より詳細には、透明性及び抗菌 効果の持続性に優れた透明膜形成抗菌剤組成物に関する。  [0001] The present invention relates to a transparent film-forming liquid antibacterial agent composition, and more particularly to a transparent film-forming antibacterial agent composition excellent in transparency and durability of antibacterial effect.
背景技術  Background art
[0002] 現在の住環境は、エアコンによる冷暖房効率の向上や、花粉の室内への進入を防 ぐ等の観点から、高度に密閉化されている。そのため、浴室内や台所まわり、窓のサ ッシといった水分の多い場所にあっては、真菌や細菌などの菌類が繁殖し易ぐこの ような菌類の繁殖を防止するべぐ様々な抗菌剤がこれまでに開発されてきた。  [0002] The current living environment is highly sealed from the viewpoints of improving the efficiency of air conditioning with an air conditioner and preventing pollen from entering the room. For this reason, various antibacterial agents that prevent the growth of fungi such as fungi and bacteria in the bathroom, around the kitchen, and in window sashes are easy to grow. It has been developed so far.
[0003] しかし、浴室内や台所まわり、窓のサッシ等の場所は水分に曝されやすいため、そ れらの場所に抗菌剤を散布 *塗布しても、水分によって抗菌成分が溶出してしまい、 抗菌効果があまり持続せず、持続的な効果を得るためには、抗菌剤を力なり頻繁に 散布しなければならな力 た。そこで、抗菌剤の持続性を向上させる試みがなされて きた。例えば特許文献 1には、防カビ成分に加えて、撥水性被膜形成成分として、炭 素鎖長 10〜14のジアルキルジメチルアンモ-ゥム塩を配合することによって、防カビ 剤の防カビ効果の持続性を向上させることが記載されている。しかし、抗菌剤の持続 '性は十分とはいえなかった。  [0003] However, places in the bathroom, around the kitchen, window sashes, etc. are easily exposed to moisture, so even if an antibacterial agent is sprayed on those places * even if applied, antibacterial components are eluted by moisture. The antibacterial effect did not last much, and in order to obtain a lasting effect, it was necessary to apply the antibacterial agent frequently and frequently. Thus, attempts have been made to improve the durability of antibacterial agents. For example, Patent Document 1 includes a fungicidal effect of a fungicide by adding a dialkyldimethyl ammonium salt having a carbon chain length of 10 to 14 as a water repellent film forming component in addition to a fungicide component. It is described to improve sustainability. However, the sustainability of antibacterial agents was not sufficient.
[0004] また、防カビ剤としてよく用いられるチアベンダゾール等は、アルコールや水等の溶 媒への溶解度が低いので、適当な溶媒に単に溶解させてその溶解液を散布'塗布し ても、すぐに析出して白濁してしまうため、持続的な防カビ効果を得ることはより困難 であった。カロえて、特に屋内用途では、チアベンダゾール等の析出 ·白濁は、清潔感 を損われた印象を見る者に与えるため、実用上の使用感には問題があった。  [0004] In addition, thiabendazole, which is often used as an antifungal agent, has low solubility in solvents such as alcohol and water, so even if it is simply dissolved in an appropriate solvent and sprayed, the solution is applied immediately. It was more difficult to obtain a continuous fungicidal effect because it precipitated in the water and became cloudy. In particular, for indoor use, precipitation and white turbidity of thiabendazole gave viewers the impression that cleanliness was impaired, so there was a problem in practical use.
[0005] 一方、特許文献 2には、藻類'カビ類が繁殖して生物汚染が進んでいる建築物外 装部材に、少ない工程で短時間かつ経済的に塗布でき、生物汚染した部分を容易 に改修しうる水系防藻 (力ビ)塗料として、「合成樹脂ラテックスを主成分とする建築物 外装部材用の水系防藻 (力ビ)塗料であって、榭脂固形分 100重量部に対して 0. 01 〜 10重量部の防藻剤又は防カビ剤、及び 0〜5重量部の増粘剤を配合し、かつ榭 脂固形分濃度を 1〜30重量%に調整することを特徴とする水系防藻 (力ビ)塗料」が 記載されている。 [0005] On the other hand, in Patent Document 2, it can be applied in a short time and economically to a building exterior member in which algae 'fungi have propagated and biological contamination has progressed, and biologically contaminated parts can be easily applied. As a water-based anti-algae (strength) paint that can be renovated into a water-based anti-algae (strength) coating for exterior parts of buildings with synthetic resin latex as the main component, 0. 01 Water-based anti-algae characterized by containing ~ 10 parts by weight of an anti-algae or fungicide and 0-5 parts by weight of a thickener and adjusting the resin solids concentration to 1-30% by weight (Strong paint) "is described.
特許文献 2には、該塗料を透明塗膜とし得ることが記載されているが、これは榭脂 固形分濃度を低く抑えて膜厚を薄くすることによりなし得る (特許文献 2の段落番号 0 031の記載参照)ものである。また、このことと、「塗布後の膜厚は、特に限定されない 力 0. 5〜20 μ m、好ましくは膜厚 1〜15 μ mとすることができる。これは、従来の膜 厚(20〜200 /ζ πι)より薄いため、本発明による塗布面では、透明な塗膜部分とそれ 以外の部分の違 、を見分けることができな 、ほどである。」との記載 (特許文献 2の段 落番号 0040の記載参照)、及び「塗料の榭脂固形分濃度は、 · · · 1重量%よりも少な いど塗膜が形成されず、かつ防藻、防カビ性効果の持続性が期待できない。一方、 3 0重量%よりも多いど塗膜厚が厚くなりすぎて、塗装していない部分との外観 (艷)に 差が生じるので好ましくな 、。」との記載 (特許文献 2の段落番号 0030の記載参照) を合わせて考慮すると、特許文献 2においては膜厚をできるだけ薄くしたいところ、合 成榭脂ラテックスという成分の性質上、あまり榭脂固形分濃度を薄くするど塗膜が形 成されず、例えば膜厚 0. 5 m未満の塗膜を形成することができないであろうことが 読み取れる。膜厚が例えば 5 m以上である場合、特許文献 2の塗料のように、建築 物外装部材に用いるものであれば (特許文献 2の段落番号 0034の記載参照)、その 透明性は十分である力もしれないが、鏡やタイル目地に用いる屋内用途の場合はよ り近くで目にすることになるため、特許文献 2の塗料は室内用途として十分な透明性 は得られないと考えられる。  Patent Document 2 describes that the paint can be made into a transparent coating film, but this can be achieved by reducing the thickness of the resin solids concentration and reducing the film thickness (paragraph number 0 of Patent Document 2). 031). In addition, this indicates that “the film thickness after coating is not particularly limited, and can be 0.5 to 20 μm, preferably 1 to 15 μm. Since it is thinner than ~ 200 / ζπι), the difference between the transparent coating film portion and the other portions cannot be distinguished on the coated surface according to the present invention. ”(Patent Document 2) (Refer to the description of Step No. 0040) and “The concentration of the solids in the resin is less than 1% by weight. On the other hand, if it exceeds 30% by weight, the coating thickness becomes too thick, which is preferable because it causes a difference in appearance (外 観) from the unpainted part. ”(Patent Document 2 In addition, in Patent Document 2, it is desirable to make the film thickness as thin as possible. The nature of the components of the latex, much throat coating to reduce the 榭脂 solid concentration not is made form, read it would not be able to form a film thickness 0. 5 m below the coating, for example. For example, when the film thickness is 5 m or more, if it is used for a building exterior member like the paint of Patent Document 2 (see the description in paragraph No. 0034 of Patent Document 2), the transparency is sufficient. Although it cannot be applied, it is considered that the paint of Patent Document 2 cannot provide sufficient transparency for indoor use because it will be seen closer in the case of indoor use for mirrors and tile joints.
[0006] このような状況下において、対象に散布した場合の透明性及び透明性の持続性が 高く、かつ抗菌効果の持続性も高 、透明膜形成抗菌剤組成物が求められて ヽたが、 そのような透明膜形成抗菌剤組成物はこれまで知られていな力つた。  [0006] Under such circumstances, there has been a need for a transparent film-forming antibacterial agent composition that is highly transparent when applied to a subject and has a high persistence in antibacterial properties and a high antibacterial effect. Such a transparent film-forming antibacterial composition has not been known so far.
[0007] 特許文献 1 :特開平 10— 230976号公報  [0007] Patent Document 1: Japanese Patent Laid-Open No. 10-230976
特許文献 2:特開 2003 - 292868号公報  Patent Document 2: Japanese Patent Laid-Open No. 2003-292868
発明の開示  Disclosure of the invention
発明が解決しょうとする課題 [0008] 本発明の課題は、刺激性が低ぐ対象に散布した場合の透明性及び透明性の持 続性が高ぐかつ抗菌効果の持続性も高い透明膜形成液状抗菌剤組成物を提供す ること〖こある。以下、「透明膜形成液状抗菌剤組成物」を、単に「抗菌剤組成物」という 課題を解決するための手段 Problems to be solved by the invention [0008] An object of the present invention is to provide a transparent film-forming liquid antibacterial agent composition having a high transparency and a high persistence of transparency when applied to a subject with low irritation and a high durability of the antibacterial effect. There is something to do. Hereinafter, “transparent film-forming liquid antibacterial agent composition” is simply referred to as “antibacterial agent composition”.
[0009] 本発明者らは、疎水性部位を有する有機ポリマーと、抗菌成分と、アルコール系溶 媒とを用いると、透明性、透明性の持続性、及び抗菌効果の持続性に優れた透明膜 が得られることを見い出し、本発明を完成するに至った。 [0009] The present inventors use transparent organic polymer having a hydrophobic site, an antibacterial component, and an alcohol-based solvent to achieve transparency that is excellent in transparency, durability of transparency, and durability of antibacterial effect. It has been found that a film can be obtained, and the present invention has been completed.
[0010] すなわち本発明は、以下の発明に関する。 [0010] That is, the present invention relates to the following inventions.
(1)疎水性部位を有する有機ポリマーと、抗菌成分と、水又はアルコール系溶媒とを 含有することを特徴とする透明膜形成液状抗菌剤組成物。  (1) A transparent film-forming liquid antibacterial agent composition comprising an organic polymer having a hydrophobic site, an antibacterial component, and water or an alcohol solvent.
(2)疎水性部位が、非極性基であることを特徴とする(1)に記載の透明膜形成液状 抗菌剤組成物。  (2) The transparent film-forming liquid antibacterial composition according to (1), wherein the hydrophobic site is a nonpolar group.
(3)非極性基力 アルキル基、アルケニル基、フ -ル基、縮合多環フエニル基、及 び鎖状多環フエニル基力 なる群力 選ばれるいずれか 1種又は 2種以上であること を特徴とする(2)に記載の透明膜形成液状抗菌剤組成物。  (3) Nonpolar basic force Alkyl group, alkenyl group, fullyl group, condensed polycyclic phenyl group, and chain polycyclic phenyl group power are selected from any one or more selected. The transparent film-forming liquid antibacterial composition according to (2), characterized in that
(4)  (Four)
有機ポリマーが、さらに親水性部位を有して 、ることを特徴とする(1)〜(3)の 、ずれ かに記載の透明膜形成液状抗菌剤組成物。  The transparent film-forming liquid antibacterial composition according to any one of (1) to (3), wherein the organic polymer further has a hydrophilic site.
(5)親水性部位が、極性基であることを特徴とする (4)に記載の透明膜形成液状抗 菌剤組成物。  (5) The transparent film-forming liquid antibacterial composition according to (4), wherein the hydrophilic part is a polar group.
(6)極性基力 カルボキシル基、スルホン酸基、スルホアミド基、アミド基、アミノ基、ィ ミノ基、ヒドロキシ基、 4級ァミノ基、ォキシァミノ基、ジァゾニゥム基、グァ-ジン基、ヒ ドラジン基、リン酸基、ケィ酸基、アルミン酸基、二トリル基、及びチォアルコール基か らなる群力 選ばれるいずれか 1種又は 2種以上であることを特徴とする(5)に記載 の透明膜形成液状抗菌剤組成物。  (6) Polar group power Carboxyl group, sulfonic acid group, sulfoamide group, amide group, amino group, imino group, hydroxy group, quaternary amino group, oxiamino group, diazonium group, guanidine group, hydrazine group, phosphorus The transparent film formation according to (5), characterized in that it is one or two or more selected from the group force consisting of an acid group, a carboxylic acid group, an aluminate group, a nitrile group, and a thioalcohol group Liquid antibacterial composition.
(7)有機ポリマーが、親水性部位を有するモノマーと、疎水性部位を有するモノマー との共重合ポリマーであることを特徴とする(1)〜(6)の 、ずれかに記載の透明膜形 成液状抗菌剤組成物。 (7) The transparent film form according to any one of (1) to (6), wherein the organic polymer is a copolymer of a monomer having a hydrophilic part and a monomer having a hydrophobic part Composition liquid antibacterial agent composition.
(8)有機ポリマーが、スチレンマレイン酸共重合体であることを特徴とする(1)〜(7) の!ヽずれかに記載の透明膜形成液状抗菌剤組成物。  (8) The transparent film-forming liquid antibacterial composition according to any one of (1) to (7), wherein the organic polymer is a styrene maleic acid copolymer.
(9)形成された透明膜のヘイズ率が 5以下であることを特徴とする(1)〜(8)の ヽず れかに記載の透明膜形成液状抗菌剤組成物。  (9) The transparent film-forming liquid antibacterial composition according to any one of (1) to (8), wherein the formed transparent film has a haze ratio of 5 or less.
(10)抗菌成分が、 20°Cの水 lOOgに対する溶解度が 0. 2g以下であることを特徴と する(1)〜(9)の 、ずれかに記載の透明膜形成液状抗菌剤組成物。  (10) The transparent film-forming liquid antibacterial composition according to any one of (1) to (9), wherein the antibacterial component has a solubility in water of 1Og at 20 ° C of 0.2 g or less.
(11)抗菌成分が、防カビ成分であることを特徴とする(1)〜(10)のいずれかに記載 の透明膜形成液状抗菌剤組成物。  (11) The transparent film-forming liquid antibacterial composition according to any one of (1) to (10), wherein the antibacterial component is an antifungal component.
(12)防カビ成分が、チアベンダゾール、 3 ョードー 2 プロパギルブチルカルバメ イト、 1, 2 ベンゾトリァゾリン一 3—オン、ジョードメチル一 p トリルスルフォン、 2, 3 , 5, 6テトラクロ口一 4— (メチルスルフォ -ル)ピリジン、及び 1— (2— (2, 4 ジクロ 口フエ-ル) 2—(2—プロべ-ルォキシ)ェチル) 1H—イミダゾール(イマザリル) 力 なる群力 選ばれるいずれか 1種又は 2種以上であることを特徴とする(11)に記 載の透明膜形成液状抗菌剤組成物。  (12) Antifungal ingredients are thiabendazole, 3 odor-2 propargyl butyl carbamate, 1, 2 benzotriazoline 1-one, jodomethyl 1-p-tolylsulfone, 2, 3, 5, 6 (Methylsulfuryl) pyridine, and 1— (2- (2,4 Diclonal Methyl) 2- (2-Probeoxy) ethyl) 1H-imidazole (imazalyl) Power Group force selected Any 1 The transparent film-forming liquid antibacterial composition according to (11), wherein the composition is a seed or two or more kinds.
(13)有機ポリマーの水に対する溶解度が 5〜5000ppmであることを特徴とする(1) 〜(12)の ヽずれかに記載の透明膜形成液状抗菌剤組成物。  (13) The transparent film-forming liquid antibacterial composition according to any one of (1) to (12), wherein the solubility of the organic polymer in water is 5 to 5000 ppm.
(14)アルコール系溶媒力 20〜100重量0 /0の範囲内のエタノールと、 80〜0重量 %の範囲内の水とからなることを特徴とする(1)〜(13)の 、ずれかに記載の透明膜 形成液状抗菌剤組成物。 (14) and ethanol in a range of alcoholic solvent power of 20 to 100 weight 0/0, characterized by comprising the water within a range of 80 to 0% by weight of (1) to (13), Zureka The transparent film-forming liquid antibacterial agent composition described in 1.
(15)有機ポリマーと、抗菌成分との重量比が、 1 : 50〜50 : 1の範囲内であることを特 徴とする(1)〜(14)の ヽずれかに記載の透明膜形成液状抗菌剤組成物。  (15) The transparent film formation according to any one of (1) to (14), wherein the weight ratio of the organic polymer to the antibacterial component is in the range of 1:50 to 50: 1. Liquid antibacterial composition.
(16)有機ポリマーが、組成物全量に対して 0. 01〜10重量%の範囲内であることを 特徴とする(1)〜(15)の ヽずれかに記載の透明膜形成液状抗菌剤組成物。  (16) The transparent film-forming liquid antibacterial agent according to any one of (1) to (15), wherein the organic polymer is in the range of 0.01 to 10% by weight based on the total amount of the composition Composition.
(17)抗菌成分が、組成物全量に対して 0. 01〜: L0重量%の範囲内であることを特 徴とする(1)〜(16)の ヽずれかに記載の透明膜形成液状抗菌剤組成物。  (17) The transparent film-forming liquid according to any one of (1) to (16), characterized in that the antibacterial component is in the range of 0.01 to L0% by weight relative to the total amount of the composition. Antibacterial composition.
(18)さらに、水溶性金属酸化物及び Z又は両親媒性の金属酸化物ナノ粒子を含有 することを特徴とする(1)〜(17)の ヽずれかに記載の透明膜形成液状抗菌剤組成 物。 (18) The transparent film-forming liquid antibacterial agent according to any one of (1) to (17), further comprising a water-soluble metal oxide and Z or amphiphilic metal oxide nanoparticles. composition object.
(19)両親媒性の金属ナノ粒子が、加水分解性基及び Z又は水酸基を合計で 1以上 有する金属キレートイ匕合物の加水分解生成物であることを特徴とする(18)に記載の 透明膜形成液状抗菌剤組成物。  (19) The transparent product according to (18), wherein the amphiphilic metal nanoparticles are hydrolysis products of metal chelate compounds having a total of 1 or more hydrolyzable groups and Z or hydroxyl groups. A film-forming liquid antibacterial agent composition.
(20)両親媒性の金属酸ィ匕物ナノ粒子力 粒子径 Inn!〜 30nmのナノ粒子であるこ とを特徴とする(18)又は(19)に記載の透明膜形成液状抗菌剤組成物。  (20) Amphiphilic metal oxide nanoparticle force Particle size Inn! The transparent film-forming liquid antibacterial composition according to (18) or (19), wherein the composition is a nanoparticle of ˜30 nm.
(21)両親媒性の金属酸ィ匕物ナノ粒子が、酸ィ匕チタンナノ粒子であることを特徴とす る(18)〜(20)の 、ずれかに記載の透明膜形成液状抗菌剤組成物。  (21) The transparent film-forming liquid antibacterial composition according to any one of (18) to (20), wherein the amphiphilic metal oxide nanoparticles are acid titanium nanoparticles. object.
(22) (1)〜(21)のいずれかに記載の透明膜形成液状抗菌剤組成物を、窓用透明 膜形成液状抗菌剤組成物、台所用透明膜形成液状抗菌剤組成物及び浴室用透明 膜形成液状抗菌剤組成物の!ヽずれかとして使用する方法。  (22) The transparent film-forming liquid antibacterial agent composition according to any one of (1) to (21), a transparent film-forming liquid antibacterial agent composition for windows, a transparent film-forming liquid antibacterial agent composition for kitchens, and a bathroom A method for use as a transparent film-forming liquid antibacterial agent composition.
(23) (1)〜(21)のいずれかに記載の透明膜形成液状抗菌剤組成物が、容器に収 容されてなることを特徴とするスプレー型抗菌剤。  (23) A spray-type antibacterial agent, wherein the transparent film-forming liquid antibacterial agent composition according to any one of (1) to (21) is contained in a container.
図面の簡単な説明 Brief Description of Drawings
[図 1]スチレン無水マレイン酸共重合体 (榭脂 A)の13 C—NMRチャートを示す図であ る。 FIG. 1 is a diagram showing a 13 C-NMR chart of a styrene maleic anhydride copolymer (resin A).
[図 2]スチレン無水マレイン酸共重合体加水分解物 (榭脂 a)の13 C— NMRチャートを 示す図である。 FIG. 2 is a diagram showing a 13 C-NMR chart of styrene-maleic anhydride copolymer hydrolyzate (resin a).
[図 3]榭脂 Aの IR ^ベクトルを示す図である。  FIG. 3 is a diagram showing IR ^ vector of rosin A.
[図 4]榭脂 aの IR ^ベクトルを示す図である。 FIG. 4 is a diagram showing the IR ^ vector of rosin a.
[図 5]榭脂 Bの IR ^ベクトルを示す図である。 FIG. 5 is a diagram showing IR ^ vector of rosin B.
[図 6]榭脂 bの IR ^ベクトルを示す図である。 FIG. 6 is a diagram showing an IR ^ vector of rosin b.
[図 7]榭脂 Cの IR ^ベクトルを示す図である。 FIG. 7 is a diagram showing IR ^ vector of rosin C.
[図 8]榭脂 cの IR ^ベクトルを示す図である。 FIG. 8 is a diagram showing the IR ^ vector of rosin c.
[図 9]榭脂 Dの IR ^ベクトルを示す図である。 FIG. 9 is a diagram showing IR ^ vector of rosin D.
[図 10]榭脂 dの IR ^ベクトルを示す図である。 FIG. 10 is a diagram showing an IR ^ vector of rosin d.
[図 11]榭脂 Eの IRスペクトルを示す図である。 FIG. 11 is a diagram showing an IR spectrum of rosin E.
[図 12]榭脂 eの IR ^ベクトルを示す図である。 [図 13]榭脂 Fの IR ^ベクトルを示す図である。 FIG. 12 is a diagram showing IR ^ vector of rosin e. FIG. 13 is a diagram showing IR ^ vector of rosin F.
[図 14]榭脂 fの IR ^ベクトルを示す図である。  FIG. 14 is a diagram showing the IR ^ vector of rosin f.
[図 15]榭脂 Gの IR ^ベクトルを示す図である。  FIG. 15 is a diagram showing IR ^ vector of rosin G.
[図 16]榭脂 gの IRスペクトルを示す図である。  FIG. 16 shows an IR spectrum of rosin g.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0012] 本発明の抗菌剤組成物は、疎水性部位を有する有機ポリマーと、抗菌成分と、アル コール系溶媒とを含有する限り特に制限はされない。 [0012] The antibacterial agent composition of the present invention is not particularly limited as long as it contains an organic polymer having a hydrophobic site, an antibacterial component, and an alcohol solvent.
本発明の効果の詳細な作用機作は不明であるが、疎水性部位を有する有機ポリマ 一と、抗菌成分との間に何らかの相互作用が働いた結果、抗菌成分を安定化し、抗 菌成分の析出が抑制されたものと推察される。  Although the detailed mechanism of the effect of the present invention is unclear, as a result of some interaction between the organic polymer having a hydrophobic site and the antibacterial component, the antibacterial component is stabilized and the antibacterial component Presumably, the precipitation was suppressed.
[0013] 上記有機ポリマーとは、疎水性部位を有する有機ポリマーをいう。疎水性部位とし ては、特に制限されないが、例えばアルキル基;ビニル基、ビニリデン基、ェチニル基 等のァルケ-ル基;フエ-ル基、ナフチル基、アントラ-ル基等の縮合多環フエ-ル 基;ビフヱ-ル基、ターフ ニル基等の鎖状多環フヱ-ル基;その他の非極性基等を ί列示することができる。 [0013] The organic polymer refers to an organic polymer having a hydrophobic site. The hydrophobic site is not particularly limited, but examples thereof include alkyl groups; vinyl groups, vinylidene groups, alkenyl groups such as ethynyl groups; condensed polycyclic phenols such as phenyl groups, naphthyl groups, and anthral groups. The following can be listed: a ru group; a chain polycyclic fur group such as a biphenyl group and a terfenyl group; and other nonpolar groups.
[0014] 本発明に用いる有機ポリマーは、親水性部位を有していなくてもよいが、より優れた 透明性、透明性の持続性、及び抗菌効果の持続性の観点から、さらに親水性部位を 有していることが好ましい。  [0014] The organic polymer used in the present invention may not have a hydrophilic site, but from the viewpoint of superior transparency, durability of transparency, and durability of antibacterial effect, the hydrophilic polymer is further. It is preferable to have.
親水性部位としては、特に制限されないが、例えばカルボキシル基及びその金属 塩若しくはァミン塩;スルホン酸基及びその金属塩若しくはァミン塩;スルホアミド基; アミド基;アミノ基;イミノ基;ヒドロキシ基; 4級ァミノ基;ォキシァミノ基;ジァゾ -ゥム基; グァ-ジン基;ヒドラジン基;リン酸基;ケィ酸基;アルミン酸基;-トリル基;チオアルコ ール基;その他の極性基等を挙げることができ、中でもカルボキシル基、スルホン酸 基、スルホアミド基、アミド基、アミノ基、イミノ基、ヒドロキシ基、 4級ァミノ基、ォキシァ ミノ基、ジァゾニゥム基、グァニジン基、ヒドラジン基、リン酸基、ケィ酸基、アルミン酸 基、二トリル基、及びチォアルコール基力 なる群力 選ばれるいずれか 1種又は 2種 以上を好ましく例示することができる。  The hydrophilic site is not particularly limited, and examples thereof include a carboxyl group and a metal salt or an amine salt thereof; a sulfonic acid group and a metal salt or an amine salt thereof; a sulfoamide group; an amide group; an amino group; an imino group; a hydroxy group; Amino group; oxiamino group; diazo-um group; guanidine group; hydrazine group; phosphoric acid group; carboxylic acid group; aluminate group; -tolyl group; thioalcohol group; Among them, carboxyl group, sulfonic acid group, sulfoamide group, amide group, amino group, imino group, hydroxy group, quaternary amino group, oxyamino group, diazonium group, guanidine group, hydrazine group, phosphoric acid group, and caiic acid group , Aluminate group, nitrile group, and thioalcohol group group power of any one selected from preferably one or two or more It can be.
[0015] 本発明に用いる有機ポリマーとして、より具体的には、親水性部位を有するモノマ 一と疎水性部位を有するモノマーとの共重合体や、親水性部位及び疎水性部位を 有するモノマーの重合体等を挙げることができる。 [0015] More specifically, the organic polymer used in the present invention is a monomer having a hydrophilic portion. And a copolymer of one and a monomer having a hydrophobic part, and a polymer of a monomer having a hydrophilic part and a hydrophobic part.
なお、透明性及び透明性の持続性がより高ぐかつ抗菌効果の持続性もより高い膜 が得られる観点から、親水性部位を有するモノマーと疎水性部位を有するモノマーと の共重合体は、両モノマーのランダム共重合体であることが好まし 、。  From the viewpoint of obtaining a film having higher transparency and transparency persistence and higher durability of the antibacterial effect, a copolymer of a monomer having a hydrophilic part and a monomer having a hydrophobic part is: Preferred is a random copolymer of both monomers.
[0016] 親水性部位を有するモノマーとしては、例えば、アクリル酸、メタクリル酸、マレイン 酸、ィタコン酸などのモノ又はジカルボン酸モノマー、 2—アタリロイルォキシェチル - 2-ヒドロキシェチルフタル酸、 2 -ヒドロキシ - 3—フエノキシプロピルアタリレート、 2—ヒドロキエチルメタタリレート、 N—メチロールアクリルアミドなど水酸基含有モノマ 一、スチレンスルホン酸ナトリウム、スルホン化イソプレンなどスルホン酸基含有モノマ 一、アクリルアミド、メタクリルアミドなどのアミド化合物モノマー等を挙げることができ、 中でもアクリル酸、メタクリル酸、マレイン酸、ィタコン酸などのモノまたはジカルボン酸 モノマーを好ましく挙げることができ、マレイン酸、ィタコン酸などのジカルボン酸モノ マーをより好ましく挙げることができる。  [0016] Examples of the monomer having a hydrophilic portion include mono- or dicarboxylic acid monomers such as acrylic acid, methacrylic acid, maleic acid, and itaconic acid, 2-atallylooxychetyl-2-hydroxyethyl phthalic acid, Monomers containing hydroxyl groups such as 2-hydroxy-3-phenoxypropyl acrylate, 2-hydroxyethyl methacrylate, N-methylol acrylamide, monomers containing sulfonic groups such as sodium styrenesulfonate and sulfonated isoprene, acrylamide, methacryl Examples include amide compound monomers such as amides. Among them, mono- or dicarboxylic acid monomers such as acrylic acid, methacrylic acid, maleic acid, and itaconic acid can be preferably exemplified, and dicarboxylic acid monomers such as maleic acid and itaconic acid. More preferred It can be mentioned.
なお、本発明に用いる親水性部位を有するモノマーは、モノマーの状態では親水 性部位を有して 、なくてもよく、抗菌剤組成物中に含まれる有機ポリマーの状態で親 水性部位を有していればよい。例えば、無水マレイン酸モノマーは、親水性部位を有 さないが、抗菌剤組成物中に含まれる有機ポリマーの状態において、無水マレイン 酸の酸無水物基が加水分解により開環し、親水性部位であるカルボキシル基が生成 して 、れば、親水性部位を有する有機ポリマーであると 、える。  The monomer having a hydrophilic moiety used in the present invention may or may not have a hydrophilic moiety in the monomer state, and has a hydrophilic moiety in the state of the organic polymer contained in the antibacterial agent composition. It only has to be. For example, a maleic anhydride monomer does not have a hydrophilic site, but in the state of an organic polymer contained in the antibacterial agent composition, the anhydride group of maleic anhydride is opened by hydrolysis, resulting in a hydrophilic site. If a carboxyl group is generated, it is considered as an organic polymer having a hydrophilic portion.
マレイン酸、ィタコン酸などのジカルボン酸モノマーの場合、有機ポリマーの状態で カルボキシル基を 1つ、エステルを 1つ有していればよいが、より優れた本発明の効 果を得る観点から、カルボキシル基を 2つ有して 、ることが好まし 、。  In the case of a dicarboxylic acid monomer such as maleic acid or itaconic acid, it is sufficient that it has one carboxyl group and one ester in the state of an organic polymer, but from the viewpoint of obtaining a more excellent effect of the present invention, carboxyl It is preferable to have two groups.
[0017] 疎水性部位を有するモノマーとしては、例えば、メチル (メタ)アタリレート、ェチル (メ タ)アタリレート、 (イソ)プロピル (メタ)アタリレート、 (イソ又はターシャリー)ブチル (メタ )アタリレート、 (イソ)ァミル (メタ)アタリレート、シクロへキシル (メタ)アタリレート、 2- ェチルへキシル (メタ)アタリレート、 (イソ)ォクチル (メタ)アタリレート、 (イソ)デシル( ト等の炭素数 1〜18のアルキル基を有する (メタ)アクリル酸エステル類;スチレン、ビ -ルトルエン、 2—メチノレスチレン、クロロスチレン等のスチレン系モノマー、ベンジル (メタ)アタリレート等の芳香環含有モノマー等を挙げることができ、中でもスチレン、ビ -ルトルエン、 2—メチルスチレン、クロロスチレン等のスチレン系モノマーを好ましく 挙げることができ、スチレンをより好ましく挙げることができる。 [0017] Monomers having a hydrophobic site include, for example, methyl (meth) acrylate, ethyl (meth) acrylate, (iso) propyl (meth) acrylate, (iso or tertiary) butyl (meth) acrylate. , (Iso) amyl (meth) acrylate, cyclohexyl (meth) acrylate, 2- ethenyl hexyl (meth) acrylate, (iso) octyl (meth) acrylate, (iso) decyl ( (Meth) acrylic acid esters having an alkyl group having 1 to 18 carbon atoms such as styrene; styrene monomers such as styrene, vinyltoluene, 2-methylolstyrene, chlorostyrene, and fragrances such as benzyl (meth) acrylate Examples thereof include ring-containing monomers, among which styrene monomers such as styrene, vinyltoluene, 2-methylstyrene, and chlorostyrene can be preferably exemplified, and styrene can be more preferably exemplified.
[0018] 親水性部位及び疎水性部位を有するモノマーとしては、例えば、 N—ェチル (メタ) アクリルアミド、 N—シクロプロピル (メタ)アクリルアミド、 N—イソプロピル (メタ)アタリ ルアミド、 N—n—プロピル (メタ)アクリルアミド、 N—メチル—N—ェチル (メタ)アタリ ルアミド、 N, N—ジェチル (メタ)アクリルアミド、 N—メチルー N—イソプロピル (メタ) アクリルアミド、 N—メチル—N—n—プロピル (メタ)アクリルアミド、 N—ビュルピロリド ン、 N—ビニルカプロラタタム、 N—イソプロぺニルピロリドン、 N—イソプロぺニルカプ 口ラタタム、 N— (メタ)アタリロイルピロリジン、 N— (メタ)アタリロイルビペリジン等を挙 げることができる。 [0018] Examples of the monomer having a hydrophilic part and a hydrophobic part include N-ethyl (meth) acrylamide, N-cyclopropyl (meth) acrylamide, N-isopropyl (meth) atrylamide, N-n-propyl ( (Meth) acrylamide, N-methyl-N-ethyl (meth) atrylamide, N, N-jetyl (meth) acrylamide, N-methyl-N-isopropyl (meth) acrylamide, N-methyl-N-n-propyl (meth) Acrylamide, N-Buylpyrrolidone, N-Vinylcaprolatatam, N-Isopropenylpyrrolidone, N-Isopropenylcap latatam, N- (Meth) atalyloylpyrrolidine, N- (Meth) atalyloylbiperidine I can list them.
[0019] 本発明に用いる有機ポリマーとして、具体的には、スチレンマレイン酸共重合体や その誘導体を好ましく例示することができる。スチレンマレイン酸共重合体としてはス チレン:マレイン酸の比率が 3 : 1〜1 : 1の化合物が好ましく用いられ、より好ましくは 2 : 1の化合物が用いられ、特に好ましくは 1 : 1の化合物が用いられる。スチレンマレイ ン酸共重合体の誘導体とは、スチレンマレイン酸共重合体力 誘導可能な化合物で あって、本発明において、スチレンマレイン酸共重合体と同様に用いうるものを意味 し、例えば、スチレン無水マレイン酸共重合体とアルコールを反応させることにより、 無水マレイン酸部分の酸無水物基が開環され、モノエステル Zモノカルボン酸基とな つている共重合体や、スチレンマレイン酸共重合体の芳香族基の適当な位置に、ス ルフォニル基等の置換基を有する共重合体や、スチレン無水マレイン酸共重合体の 無水マレイン酸部分がァミンによりイミド化された共重合体や、スチレン無水マレイン 酸の酸無水物基が開環されて生じたエステル基やカルボン酸基がァミンによりイミド 化された共重合体等が含まれる。  [0019] Specific examples of the organic polymer used in the present invention include styrene maleic acid copolymers and derivatives thereof. As the styrene maleic acid copolymer, a compound having a ratio of styrene: maleic acid of 3: 1 to 1: 1 is preferably used, more preferably a compound of 2: 1, and particularly preferably a compound of 1: 1. Is used. The styrene maleic acid copolymer derivative means a compound capable of inducing styrene maleic acid copolymer force and can be used in the present invention in the same manner as the styrene maleic acid copolymer. By reacting the maleic acid copolymer with alcohol, the acid anhydride group of the maleic anhydride moiety is ring-opened to form a monoester Z monocarboxylic acid group or a styrene maleic acid copolymer. A copolymer having a substituent such as a sulfonyl group at an appropriate position of the aromatic group, a copolymer in which the maleic anhydride portion of the styrene maleic anhydride copolymer is imidized with amine, or a styrene maleic anhydride Examples include an ester group formed by ring opening of an acid anhydride group or a copolymer in which a carboxylic acid group is imidized with an amine.
本発明に用いるポリマーとして、より具体的には、スチレンマレイン酸コポリマー型( TG— 750W:共栄社ィ匕学株式会社製)(スチレン無水マレイン酸重合体の無水マレ イン酸部分の酸無水物基が開環され、モノエステル Zモノカルボン酸基となって 、る 共重合体)や、 SMAエステルレジン(サートマ一社製)(スチレン無水マレイン酸重 合体の無水マレイン酸部分の酸無水物基が開環され、モノエステル Zモノカルボン 酸基となっている共重合体)や、 SMAレジン:アンモ-ゥム塩水溶液(サートマ一社 製)(スチレン無水マレイン酸重合体の無水マレイン酸部分の酸無水物基が加水分 解され、ジカルボン酸基となって!/ヽる共重合体)等を好ましく例示することができる。 More specifically, as a polymer used in the present invention, a styrene maleic acid copolymer type (TG-750W: manufactured by Kyoeisha Co., Ltd.) (a maleic anhydride maleic anhydride polymer) The acid anhydride group of the inic acid moiety is opened to form a monoester Z monocarboxylic acid group, a copolymer), SMA ester resin (manufactured by Sartoma Co., Ltd.) (styrene maleic anhydride polymer maleic anhydride) Copolymers in which the acid anhydride group of the acid moiety is opened to form a monoester Z monocarboxylic acid group), SMA resin: Ammonium salt aqueous solution (manufactured by Sartoma Co., Ltd.) Preferred examples include copolymers in which the acid anhydride group of the maleic anhydride portion of the polymer is hydrolyzed to form a dicarboxylic acid group.
[0020] 有機ポリマーの分子量は、本発明の効果が得られる限り特に制限されないが、例え ば数平均分子量が 1 ,000〜 100,000の範囲内であることが好ましく、 2,000〜20,0 00の範囲内であることがより好ましい。 [0020] The molecular weight of the organic polymer is not particularly limited as long as the effects of the present invention can be obtained. For example, the number average molecular weight is preferably in the range of 1,000 to 100,000, and in the range of 2,000 to 20,000. More preferably, it is within.
また、有機ポリマーの水への溶解度は 5〜5000ppmであることが好ましぐ 10〜20 OOppmであることがより好まし!/、。  Also, the solubility of the organic polymer in water is preferably 5 to 5000 ppm, more preferably 10 to 20 OOppm! /.
溶解度の異なる複数の有機ポリマーを混合して使用することも好ましく行なわれる 力 その場合は少なくとも 1種類の有機ポリマーの溶解度が 5〜5000ppmであること が好ましぐ溶解度が 5〜5000ppmの榭脂の有機ポリマー全体中に占める重量割 合は 30%以上であることがより好まし 、。  It is also preferable to use a mixture of a plurality of organic polymers having different solubilities. In that case, it is preferable that the solubility of at least one organic polymer is 5 to 5000 ppm. More preferably, the weight percentage of the whole organic polymer is 30% or more.
有機ポリマーの溶解度の測定方法は後述の実施例中に記載する。  The method for measuring the solubility of the organic polymer is described in the examples described later.
[0021] 本発明に用いる抗菌成分としては、公知の防カビ成分、抗細菌成分、抗酵母成分 、抗ウィルス成分等を挙げることができ、例えば、水への溶解度が 0. 2g以下で、エタ ノールへの溶解度が 0. 2g以上、好ましくは 0. 5g以上であり、かつ、常温で固体であ る抗菌成分は溶解して使用することができる。 [0021] Examples of the antibacterial component used in the present invention include known antifungal components, antibacterial components, antiyeast components, antiviral components, and the like. For example, the solubility in water is 0.2 g or less, The antibacterial component which has a solubility in a diol of 0.2 g or more, preferably 0.5 g or more and is solid at room temperature can be used after being dissolved.
なお、本願明細書における「抗菌成分の水への溶解度」や「抗菌成分のエタノール への溶解度」とは、それぞれ、 20°Cの水 100gへの溶解度、 20°Cのエタノール 100g への溶解度を表す。水への溶解度が 0. 2gZl00g以下でエタノールへの溶解度が 0. 2gZl00g以上である抗菌成分は、本発明に用いる有機ポリマーとの相溶性がよ り高ぐ透明性のより高い塗膜が得られる。  As used herein, “solubility of antibacterial components in water” and “solubility of antibacterial components in ethanol” refer to solubility in 100 g of water at 20 ° C and solubility in 100 g of ethanol at 20 ° C, respectively. To express. An antibacterial component having a solubility in water of not more than 0.2 gZl00 g and a solubility in ethanol of not less than 0.2 gZl00 g is more compatible with the organic polymer used in the present invention and can provide a highly transparent coating film. .
[0022] 上記抗菌成分として、特に防カビ成分を好適に例示することができる。防カビ剤のう ち、溶解して使用することができる防カビ剤としては、チアベンダゾール (TBZ)、 3— ョードー 2—プロパギルブチルカルバメイト、 1, 2—べンゾトリァゾリンー3—オン、ジョ 一ドメチル一 p トリルスルフォン、 2, 3, 5, 6テトラクロ口一 4— (メチルスルフォ -ル) ピリジン、 1— (2— (2, 4 ジクロロフエ-ル)—2— (2—プロべ-ルォキシ)ェチル) 1H—イミダゾール (イマザリル)等を具体的に例示することができる力 中でも、チ ァベンダゾール、 3 ョードー 2 プロパギルブチルカルバメイトが好ましぐチアベン ダゾールがより好ましい。また、防カビ剤のうち、分散させて使用することができる防力 ビ剤としては、 2—メトキシカルボニルァミノべンズイミダゾール、 2—ピリジンチオール 1 オキサイド亜鉛塩等を好適な具体例として例示することができる。 また、抗細菌 '抗酵母成分としては 2, 4, 4' トリクロロー 2' ハイド口キシジフエ- ルエーテル、 1, 2 べンゾチアゾロン 3、 N—(フルォロジクロロメチルチオ) フタ ルイミド, 2, 4, 5, 6—テトラクロ口イソフタロニトリル、 1, 3 ビス(ヒドロキシメチル)一 5, 5'—ジメチルヒダントインを具体的に例示することができる。 [0022] As the antibacterial component, a fungicide component can be particularly preferably exemplified. Antifungal agents that can be dissolved and used include thiabendazole (TBZ), 3- ododo 2-propargyl butyl carbamate, 1, 2-benzotriazolin-3-one. , Jo 1-methyl 1-p-tolylsulfone, 2, 3, 5, 6 tetrachloro 1- (methylsulfol) pyridine, 1— (2— (2, 4 dichlorophenol) —2— (2-probeloxy) Ethyl) 1H-imidazole (imazalyl), among others, thiabendazole, more preferred is thiabendazole and 3 ododo-2-propargyl butyl carbamate. Further, among the antifungal agents, examples of suitable antibiotic agents that can be used in a dispersed manner include 2-methoxycarbonylaminominobenzimidazole, 2-pyridinethiol 1 oxide zinc salt, and the like. be able to. In addition, as antibacterial 'anti-yeast components, 2, 4, 4' trichloro-2 'hydrated oxydiphenyl ether, 1, 2 benzothiazolone 3, N- (fluorochloromethylthio) phthalimide, 2, 4, 5, Specific examples thereof include 6-tetrachloro-isophthalonitrile and 1,3 bis (hydroxymethyl) -1,5'-dimethylhydantoin.
[0023] 本発明に用いる溶媒は、水又はアルコール系溶媒である力 アルコール系溶媒で あることが好ましい。 [0023] The solvent used in the present invention is preferably a strong alcohol solvent that is water or an alcohol solvent.
アルコール系溶媒としては、 100%アルコール又は含水アルコールである限り特に 制限はないが、 20〜: L00重量0 /0のアルコールを含む含水アルコールであることが好 ましぐ 30〜70重量0 /0のアルコールを含む含水アルコールであることがより好ましぐ 40〜60重量0 /0のアルコールを含む含水アルコールであることがさらに好ましい。 また、アルコール系溶媒におけるアルコールは、 1種単独でもよいし、 2種以上のァ ルコールを含んでいてもよい。アルコール系溶媒におけるアルコールとしては、ェタノ ールが好ましい。 The alcohol-based solvent is not particularly limited as long as it is 100% alcohol or aqueous alcohol,. 20 to: L00 that hydroalcoholic containing alcohol weight 0/0 is good Mashigu 30-70 wt 0/0 it is water-containing alcohol containing alcohol more preferably a hydrous alcohol containing more preferred instrument 40-60 wt 0/0 alcohol. Further, the alcohol in the alcohol solvent may be one kind alone or may contain two or more kinds of alcohols. Ethanol is preferred as the alcohol in the alcohol solvent.
[0024] 本発明の抗菌剤組成物とは、塩ィ匕ビュル基板へスプレー塗布して形成した厚さ 20 〜300nmの膜の、塗布から 24時間後のヘイズ率が 5. 0以下、好ましくは 3. 0以下、 より好ましくは 2. 0以下であり、かつ、有機ポリマーと抗菌成分とアルコール系溶媒と を含有する抗菌剤組成物を ヽぅ。  [0024] The antibacterial agent composition of the present invention is a film having a thickness of 20 to 300 nm formed by spray coating on a salted glass substrate, and the haze ratio after 24 hours from coating is preferably 5.0 or less, preferably 3. An antibacterial agent composition having an organic polymer, an antibacterial component, and an alcohol-based solvent that is 3.0 or less, more preferably 2.0 or less.
なお、本明細書におけるヘイズ率は、厚さ 0. 5mmの透明塩ィ匕ビニール板 (アタリ サンデー社製、透明硬質塩化ビニール板、ヘイズ率: 1. 0〜1. 3)にスプレー塗布し た塗膜を室温で 24時間乾燥させたサンプルを日本電色工業株式会社製の装置によ り測定された数値をいう。 形成された塗膜のヘイズ率が 5. 0以上であると塗布面が白色に着色し美観を損ね るとともに、この様な塗膜は水と接触した場合、早期に抗菌成分が溶出してしまい抗 菌効果を持続させる有効期間が短くなる。 In addition, the haze ratio in this specification was spray-coated on a 0.5 mm thick transparent salty vinyl sheet (manufactured by Atari Sunday, transparent rigid vinyl chloride board, haze ratio: 1.0 to 1.3). This is the value measured with a device made by Nippon Denshoku Industries Co., Ltd. after the coating film was dried at room temperature for 24 hours. If the haze ratio of the formed coating film is 5.0 or more, the coated surface is colored white and the aesthetic appearance is impaired. When such a coating film comes into contact with water, antibacterial components are eluted at an early stage. The effective period for maintaining the antibacterial effect is shortened.
ヘイズ率が高 ヽ塗膜を顕微鏡で拡大観察すると平滑な塗膜中に抗菌剤の結晶が 突起物として散在して 、るが、一定時間サンプルを水中に浸漬させた塗膜にぉ 、て はこの抗菌剤の結晶が消失し塗膜が平滑になっていることがわかる。一方ヘイズ率 が低 、塗膜にぉ 、ては榭脂と抗菌剤の比率がヘイズ率の高 、塗膜と同一であっても 抗菌剤の結晶は認められず、水と接触した場合も抗菌効果が長時間持続する。ヘイ ズ率の低 、塗膜にぉ 、ては塗膜状態での榭脂と抗菌剤の相溶性が良 、ために抗菌 剤の分離結晶化が起こらず、榭脂と抗菌剤が均一に溶解してゆくために抗菌効果が 長時間持続するのに対し、ヘイズ率の高い塗膜においては、榭脂と抗菌剤が分離し て抗菌剤が突起状の結晶を形成しているため、水と接触した場合には結晶化した抗 菌剤が早期に溶出してしまい、塗膜中の有効成分の濃度が減少し、塗膜の抗菌効 果の有効期間が短くなるものと推定される。  The haze ratio is high. When the coating film is magnified and observed with a microscope, the antibacterial agent crystals are scattered as protrusions in the smooth coating film. However, the coating film in which the sample is immersed in water for a certain period of time is used. It turns out that the crystal | crystallization of this antibacterial agent lose | disappeared and the coating film is smooth. On the other hand, the haze ratio is low, the coating film has a high haze ratio, and even if the ratio of the resin and the antibacterial agent is the same as that of the coating film, no antibacterial crystals are observed. The effect lasts for a long time. The haze ratio is low, and the coating film has good compatibility between the resin and the antibacterial agent, so that the antibacterial agent is not separated and crystallized, and the resin and the antibacterial agent are uniformly dissolved. The antibacterial effect lasts for a long time, but in the coating film with a high haze rate, the antibacterial agent and antibacterial agent are separated and the antibacterial agent forms a protruding crystal. When contacted, the crystallized antibacterial agent elutes early, and the concentration of the active ingredient in the coating film decreases, and the effective period of the antibacterial effect of the coating film is estimated to be shortened.
[0025] 本発明の抗菌剤組成物中の有機ポリマーの含有割合としては、該有機ポリマーと 0 . 1重量%の抗菌成分とを含有させた 50%エタノール水溶液を、塩化ビニル基板へ スプレー塗布して形成した厚さ 5〜500nmの膜の、塗布から 24時間後のヘイズ率が 5. 0以下となる限り特に制限されないが、抗菌剤組成物全量に対して 0. 01〜10重 量%、より好ましくは 0. 1〜5重量%、さらに好ましくは 0. 2〜3重量%、より好ましく は 0. 3〜1重量%の範囲内とすることができる。 [0025] The content of the organic polymer in the antibacterial agent composition of the present invention is such that a 50% ethanol aqueous solution containing the organic polymer and 0.1% by weight of an antibacterial component is spray-coated on a vinyl chloride substrate. The film having a thickness of 5 to 500 nm is not particularly limited as long as the haze ratio after 24 hours from application is 5.0 or less, but is 0.01 to 10% by weight with respect to the total amount of the antibacterial agent composition. More preferably, it can be in the range of 0.1 to 5% by weight, still more preferably 0.2 to 3% by weight, and more preferably 0.3 to 1% by weight.
[0026] 本発明の抗菌剤組成物中の抗菌成分の含有割合としては、該抗菌成分と 0. 3重 量%の該有機ポリマーとを含有させた 50%エタノール水溶液を、塩化ビュル基板へ スプレー塗布して形成した厚さ 5〜500nmの膜の、塗布から 24時間後のヘイズ率が 5. 0以下となる限り特に制限されないが、抗菌剤組成物全量に対して 0. 01〜10重 量%、より好ましくは 0. 03〜5重量%、さらに好ましくは 0. 07〜3重量%、より好まし くは 0. 1〜1重量%の範囲内とすることができる。 [0026] The content ratio of the antibacterial component in the antibacterial agent composition of the present invention is such that a 50% ethanol aqueous solution containing the antibacterial component and 0.3% by weight of the organic polymer is sprayed onto a bull chloride substrate. There is no particular limitation as long as the haze ratio after coating for a film of 5 to 500 nm thickness formed after coating is 5.0 or less, but it is 0.01 to 10 weight with respect to the total amount of the antibacterial agent composition. %, More preferably 0.03 to 5% by weight, still more preferably 0.07 to 3% by weight, and even more preferably 0.1 to 1% by weight.
なお、抗菌成分の含有割合の上記範囲は、抗菌成分が例えばチアベンダゾール 等の上述の具体的な抗菌成分である場合にも同様に当てはまる。 [0027] 本発明の抗菌剤組成物中の有機ポリマーと抗菌成分との配合比は、該有機ポリマ 一と該抗菌成分とを含有させた 50%エタノール水溶液を、塩化ビニル基板へスプレ 一塗布して形成した厚さ 5〜500nmの膜の、塗布から 24時間後のヘイズ率が 5. 0 以下となる限り特に制限されないが、有機ポリマーと抗菌成分との重量比を 1: 50〜5 0 : 1、より好ましくは 1 : 10〜: L0 : 1、さらに好ましくは2 : 1〜5 : 1、より好ましくは 2. 5 : 1 〜3. 5 : 1の範囲内とすることができる。 The above range of the content ratio of the antibacterial component is similarly applied when the antibacterial component is the above-described specific antibacterial component such as thiabendazole. [0027] The mixing ratio of the organic polymer and the antibacterial component in the antibacterial agent composition of the present invention is such that a 50% ethanol aqueous solution containing the organic polymer and the antibacterial component is spray-applied to a vinyl chloride substrate. The thickness ratio of the organic polymer to the antibacterial component is 1:50 to 50, as long as the haze ratio after coating for a film having a thickness of 5 to 500 nm is 5.0 or less. 1, more preferably 1:10 to: L0: 1, still more preferably 2: 1 to 5: 1, more preferably 2.5: 1 to 3.5: 1.
[0028] 本発明の抗菌剤組成物は、抗菌剤組成物を塩ィ匕ビュル基板へスプレー塗布して 形成した厚さ 5〜500nmの膜の、塗布から 24時間後のヘイズ率が 5. 0以下である 限り、疎水性部位を有する有機ポリマー、抗菌成分、及びアルコール系溶媒以外に 、任意の成分を含んでいてもよい。そのような任意成分として、例えば分散安定化剤 、界面活性剤、撥水成分、有機金属化合物、両親媒性の金属酸化物ナノ粒子等を 例示することができる。分散安定化剤や界面活性剤をさらに含んでいると、抗菌剤組 成物をより均一に溶解'分散させることができ、透明性の持続性及び抗菌効果の持 続性に資する。また、両親媒性の金属酸ィ匕物ナノ粒子をさらに含んでいると、本発明 の抗菌剤組成物を対象に散布した場合に、より優れた透明性、透明性の持続性、及 び抗菌効果の持続性が得られる。  [0028] The antibacterial agent composition of the present invention has a haze ratio of 5.0 to 24 hours after application of a 5 to 500 nm thick film formed by spray-coating the antibacterial agent composition onto a salted glass substrate. As long as it is the following, an optional component may be included in addition to the organic polymer having a hydrophobic site, the antibacterial component, and the alcohol solvent. Examples of such optional components include dispersion stabilizers, surfactants, water repellent components, organometallic compounds, amphiphilic metal oxide nanoparticles, and the like. When a dispersion stabilizer and a surfactant are further included, the antibacterial composition can be dissolved and dispersed more uniformly, which contributes to the sustainability of transparency and the sustainability of the antibacterial effect. In addition, when it further contains amphiphilic metal oxide nanoparticles, when the antibacterial agent composition of the present invention is sprayed on a target, it has better transparency, transparency persistence, and antibacterial properties. Sustained effect is obtained.
[0029] 上記分散安定化剤は、分散質を分散媒中に安定に分散させる効力を有する、解膠 剤、保護コロイド等の凝結防止剤等の剤をいい、例えば、グリコール酸、ダルコン酸、 乳酸、酒石酸、クェン酸、リンゴ酸、コハク酸等の多価カルボン酸;ヒドロキシカルボン 酸;ピロ燐酸、トリポリ燐酸等の燐酸;ァセチルアセトン、ァセト酢酸メチル、ァセト酢酸 ェチル、ァセト酢酸 n—プロピル、ァセト酢酸イソプロピル、ァセト酢酸 n—ブチル、ァ セト酢酸 sec ブチル、ァセト酢酸 tーブチル、 2, 4 へキサンージオン、 2, 4 ヘプ タンージオン、 3, 5 ヘプタンージオン、 2, 4 オクタンージオン、 2, 4 ノナンージ オン、 5—メチルーへキサンジオン等の金属原子に対して強いキレート能力を有する 多座配位子ィ匕合物;スルパース 3000、 9000、 17000、 20000、 24000 (以上、ゼ ネカ社製)、 Disperbyk— 161、 一 162、 一 163、— 164 (以上、ビックケミ一社製)等 の脂肪族ァミン系、ハイドロステアリン酸系又はポリエステルァミン;ジメチルポリシロキ サン'メチル (ポリシロキシアルキレン)シロキサン共重合体、トリメチルシロキシケィ酸 、カルボキシ変性シリコーンオイル、ァミン変性シリコーン等(特開平 9 208438号 公報、特開 2000— 53421号公報等)のシリコーンィ匕合物;等を挙げることができる。 [0029] The dispersion stabilizer refers to an agent such as a deflocculating agent, an anticoagulant such as a protective colloid having the effect of stably dispersing the dispersoid in the dispersion medium, such as glycolic acid, darconic acid, Polycarboxylic acids such as lactic acid, tartaric acid, citrate, malic acid and succinic acid; hydroxycarboxylic acids; phosphoric acids such as pyrophosphoric acid and tripolyphosphoric acid; acetylacetone, methyl acetoacetate, ethyl acetoacetate, n-propyl acetoacetate, Isopropyl acetate, n-butyl acetate, sec butyl acetate, t-butyl acetate, 2,4 hexanedione, 2,4 heptanedione, 3,5 heptanedione, 2,4 octanedione, 2,4 nonanedione , 5-methyl-hexanedione and other multidentate ligand compounds with strong chelating ability to metal atoms; Sulperce 3000, 9000, 17000, 20000 24000 (above, manufactured by General Corporation), Disperbyk-161, 1-162, 1-163,-164 (above, made by Bicchemi), etc., aliphatic amine-based, hydrostearic acid-based or polyesteramine; dimethylpolysiloxane Sun'methyl (polysiloxyalkylene) siloxane copolymer, trimethylsiloxykey acid , Silicone-modified compounds such as carboxy-modified silicone oil, amine-modified silicone and the like (JP-A-9 208438, JP-A 2000-53421, etc.).
[0030] また、上記界面活性剤としては、陰イオン系界面活性剤、陽イオン系界面活性剤、 両性界面活性剤、非イオン系界面活性剤等の界面活性剤を挙げることができる。陰 イオン系界面活性剤としては、アルキル硫酸塩、ポリオキシエチレンアルキルエーテ ル硫酸塩、スルホコハク酸塩、アマイドエーテルサルフィート型、サルコシン誘導体、 リン酸エステル型、石鹼型、スルホン酸型等の陰イオン系界面活性剤を挙げることが できる。陽イオン界面活性剤としては、アルキルトリメチルアンモ -ゥム塩、アルキルァ ミドアミン型、アルキルジメチルベンジルアンモ -ゥム塩、カチオン化高分子等の陽ィ オン界面活性剤を挙げることができる。また、非イオン界面活性剤としては、アルキロ ールアマイド型;ぺグノール L 4、ぺグノール TH— 8、ぺグノール L— 9A、ぺグノー ル L 12S、ぺグノール L— 20S、ぺグノール T— 6、ぺグノール TE— 10A、ぺグノー ル ST— 7、ぺグノール ST— 9、ぺグノール ST— 12、ぺグノール 0— 6A、ぺグノール 0— 107、ぺグノール 0—16A、ぺグノール 0— 20、ぺグノール 0— 24、ぺグノール C— 18、ぺグノール S— 4D、ぺグノール HC— 10 (東邦化学工業株式会社製)、ェ マルゲン 705、ェマルゲン 707、ェマルゲン 709 (花王株式会社製)等のポリオキシ エチレンアルキルエーテル型;ポリエチレングリコール脂肪酸エステル型;グリセリン エステル型; P.O.Eソルビット脂肪酸エステル型;ソルビタン脂肪酸エステル型;ポリオ キシエチレンソルビタン脂肪酸エステル型;ぺポール A— 0638、ぺポール B— 181、 ぺポール B— 182、ぺポール B— 184、ぺポール B— 188、ぺポール BEP— 0115 ( 東邦化学工業株式会社製)等のポリオキシエチレンポリオキシプロピレンアルキルェ 一テル型;低臭化ポリエーテル等の非イオン界面活性剤を挙げることができる。  [0030] Examples of the surfactant include surfactants such as an anionic surfactant, a cationic surfactant, an amphoteric surfactant, and a nonionic surfactant. Examples of anionic surfactants include alkyl sulfates, polyoxyethylene alkyl ether sulfates, sulfosuccinates, amide ether sulfite types, sarcosine derivatives, phosphate ester types, stone wall types, and sulfonic acid types. Examples thereof include ionic surfactants. Examples of the cationic surfactant include cationic surfactants such as alkyl trimethyl ammonium salt, alkylamide amine type, alkyl dimethyl benzyl ammonium salt, and cationized polymer. Nonionic surfactants include alkyl amide type: pegnol L 4, pegnol TH-8, pegnol L-9A, pegnol L 12S, pegnol L-20S, pegnol T-6, pegnol T-6 Gunol TE-10A, Pegnol ST-7, Pegnol ST-9, Pegnol ST-12, Pegnol 0-6A, Pegnol 0-107, Pegnol 0-16A, Pegnol 0-20, Pegnol Polyoxyethylene alkyls such as 0-24, Pegnol C-18, Pegnol S-4D, Pegnol HC-10 (manufactured by Toho Chemical Industry Co., Ltd.), Emargen 705, Emargen 707, Emargen 709 (manufactured by Kao Corporation) Ether type; Polyethylene glycol fatty acid ester type; Glycerin ester type; POE sorbite fatty acid ester type; Sorbitan fatty acid ester type; Polyoxyethylene sorbitan fatty acid ester type Poleol A— 0638, Pepol B—181, Pepol B—182, Pepol B—184, Pepol B—188, Pepol BEP—0115 (manufactured by Toho Chemical Co., Ltd.), etc. Nonionic surfactants such as oxypropylene alkyl ester type; low bromide polyether can be mentioned.
[0031] また、上記撥水成分としては、メガファック F— 475 (大日本インキ株式会社製)、メ ガファック F— 480SF (大日本インキ株式会社製)、メガファック F— 470 (大日本ィ ンキ株式会社製)、メガファック F—482 (大日本インキ株式会社製)等のフッ素系界 面活性剤や、ディックガード F— 90N (大日本インキ株式会社製)、ディックガード TE- 5A (大日本インキ株式会社製)、ディックガード F—445 (大日本インキ株式 会社製)等のフッ素系繊維加工剤を好適に例示することができる。また、この他に、ジ メチルポリシロキサン、ジメチルシリコーンオイル、メチルハイドロジェンシリコーンオイ ル、変性シリコーンオイル又はそれらのェマルジヨンを好適に例示することができる。 [0031] The water-repellent components include MegaFuck F-475 (Dainippon Ink Co., Ltd.), MegaFuck F-480SF (Dainippon Ink Co., Ltd.), MegaFuck F-470 (Dainippon Inkki). Fluorine-based surfactants such as MegaFuck F-482 (Dainippon Ink Co., Ltd.), Dickguard F-90N (Dainippon Ink Co., Ltd.), Dickguard TE-5A (Dainippon) Fluorine fiber processing agents such as Ink Co., Ltd. and Dickguard F-445 (Dainippon Ink Co., Ltd.) can be suitably exemplified. In addition to this, Preferable examples include methylpolysiloxane, dimethylsilicone oil, methylhydrogen silicone oil, modified silicone oil, and their emulsions.
[0032] 上記有機金属化合物としては、例えばチタン、ジルコユア、アルミニウム、ケィ素等 を含む有機金属化合物を例示することができる。  [0032] Examples of the organometallic compound include organometallic compounds containing, for example, titanium, zirconium oxide, aluminum, and silicon.
これらの中でも、テトライソプロピルチタネート、テトラノルマルブチルチタネート、ブ チノレチタネートダイマー、テトラ(2—ェチルへキシル)チタネート、テトラメチノレチタネ ート、チタンァセチルァセトネート、チタンテトラァセチルアセテート、チタンェチルァ セトアセテート、チタンオクタンジォレート、ジヒドロキシビス(アンモ-ゥムラクテート) チタニウム、チタンラタテート、チタントリエタノールアミネート、ポリヒドロキシチタンステ ァレート等の、チタンを含む有機金属化合物を好ましく例示することができ、チタンラ クテート等の親水性有機金属化合物を特に好ましく例示することができる。  Among these, tetraisopropyl titanate, tetranormal butyl titanate, butynoretitanate dimer, tetra (2-ethylhexyl) titanate, tetramethinoretitanate, titanium acetylacetonate, titanium tetraacetyl acetate, Titanium ethyl acetate, titanium octanediolate, dihydroxybis (ammonium lactate) Titanium, titanium ratatoate, titanium triethanolamate, polyhydroxytitanium stearate, etc. can be preferably exemplified. Particularly preferred are hydrophilic organometallic compounds such as titanium lactate.
[0033] 上記両親媒性の金属酸ィ匕物ナノ粒子としては、水溶媒に対しても有機溶媒に対し ても親和性を有するものであれば、特に制限されるものでなぐ例えば、加水分解性 基及び Z又は水酸基を合計で 2以上有する金属化合物の加水分解生成物、加水分 解性基及び Z又は水酸基を合計で 1以上有する金属キレート化合物の加水分解生 成物等を挙げることができる。両親媒性の金属酸化物ナノ粒子を本発明の抗菌剤組 成物に添加すると、該組成物を用いて成膜した場合に、膜の疎水性が向上し、その 結果として膜の耐水性が向上すると考えられる。  [0033] The amphiphilic metal oxide nanoparticles are not particularly limited as long as they have an affinity for both an aqueous solvent and an organic solvent, for example, hydrolysis. Examples thereof include hydrolysis products of metal compounds having a total of 2 or more functional groups and Z or hydroxyl groups, hydrolysis products of metal chelate compounds having 1 or more of total hydrolyzable groups and Z or hydroxyl groups, and the like. When amphiphilic metal oxide nanoparticles are added to the antibacterial agent composition of the present invention, when the film is formed using the composition, the hydrophobicity of the film is improved, and as a result, the water resistance of the film is improved. It is thought to improve.
[0034] 上記の加水分解性基及び Z又は水酸基を合計で 2以上有する金属化合物として は、加水分解性基及び Z又は水酸基を合計で 2以上有して 、る金属化合物であつ て、加水分解して両親媒性の金属酸ィ匕物ナノ粒子を製造できるものであれば特に制 限されるものではなぐここで、加水分解性基とは、水と接触して加水分解する官能 基、又は水存在下で金属原子と酸素原子を介して結合形成し得る官能基のことで、 具体的には、ハロゲン原子、アミノ基、アルコキシ基、エステル基、カルボキシ基、ホ スホリル基、イソシアナ一ト基、シァノ基、エポキシ基等を挙げることができる。そして、 加水分解性基及び Z又は水酸基を合計で 2以上有する金属化合物としては、式 (I) で表される化合物を好ましく例示することができる。  [0034] The metal compound having two or more hydrolyzable groups and Z or hydroxyl groups in total is a metal compound having two or more hydrolyzable groups and Z or hydroxyl groups in total. As long as it can produce amphiphilic metal oxide nanoparticles, the hydrolyzable group is a functional group that hydrolyzes upon contact with water, or A functional group that can form a bond through a metal atom and an oxygen atom in the presence of water, specifically, a halogen atom, an amino group, an alkoxy group, an ester group, a carboxy group, a phosphoryl group, an isocyanate group. , Cyan group, epoxy group and the like. And as a metal compound which has 2 or more of hydrolysable groups and Z or a hydroxyl group in total, the compound represented by Formula (I) can be illustrated preferably.
[0035] R MX (I) [0036] 上記式 (I)中、 Mは金属原子を表し、好ましくは周期律表第 13族〜第 15族の金属 原子であり、より具体的には、ケィ素、ゲルマニウム、スズ、鉛、チタン、ジルコニウム、 アルミニウム、インジウム、タンタル、タングステン、亜鉛等を例示することができ、これ らの中でも、ケィ素、ゲルマニウム、チタン、ジルコニウム、アルミニウムがより好ましい [0035] R MX (I) [0036] In the above formula (I), M represents a metal atom, preferably a metal atom of Group 13 to Group 15 of the periodic table, and more specifically, silicon, germanium, tin, lead, Titanium, zirconium, aluminum, indium, tantalum, tungsten, zinc, etc. can be exemplified, and among these, silicon, germanium, titanium, zirconium, and aluminum are more preferable.
[0037] 上記式 (I)中、 Rは水素原子、又は金属原子と酸素原子を介して結合を形成し得る 加水分解性基を有していてもよい有機基を表す。カゝかる有機基としては、アルキル基 、ァルケ-ル基、芳香族基等を挙げることができ、その炭素数は特に制限されないが 、通常 1〜20、好ましくは 1〜12である。力かる Rの具体例としては、メチル基、ェチ ル基、プロピル基等のアルキル基;クロロメチル基、クロ口ェチル基、クロ口プロピル基 、ブロモプロピル基、ブロモォクチル基、トリフルォロプロピル基等のハロゲン化アル キル基;グリシドキシプロピル基、エポキシシクロへキシルェチル基等のエポキシアル キル基;ァミノプロピル基、アミノブチル基等のアミノアルキル基;ビュル基、ァリル基 等のアルケニル基;アクリルォキシプロピル基、メタクリルォキシプロピル基等の (メタ) アクリルォキシアルキル基;ベンジル基等のァラルキル基;フエニル基、ナフチル基等 の芳香族基;等を挙げることができる。 In the above formula (I), R represents a hydrogen atom or an organic group which may have a hydrolyzable group capable of forming a bond via a metal atom and an oxygen atom. Examples of the organic group that can be used include an alkyl group, an alkenyl group, and an aromatic group. The carbon number of the organic group is not particularly limited, but is usually 1 to 20, preferably 1 to 12. Specific examples of R include alkyl groups such as methyl, ethyl and propyl; chloromethyl, chloroethyl, chloropropyl, bromopropyl, bromooctyl and trifluoropropyl groups. Halogenated alkyl groups such as: glycidoxypropyl group, epoxycyclohexyl group such as epoxycyclohexyl group; aminoalkyl groups such as aminoamino group, aminobutyl group; alkenyl groups such as buryl group, aryl group, etc .; And (meth) acryloxyalkyl groups such as xylpropyl group and methacryloxypropyl group; aralkyl groups such as benzyl group; aromatic groups such as phenyl group and naphthyl group;
[0038] 上記式 (I)中、 Xは Mに結合した加水分解性基又は水酸基を表す。具体的には、メ トキシ基、エトキシ基、 n—プロポキシ基、イソプロポキシ基、 n—ブトキシ基、 sec—ブ トキシ基、 t—ブトキシ基、 n—ペンチルォキシ基等の炭素数 1〜12のアルコキシ基; ヒドロキシィミノ基、ヒドロキシァミノ基、エノキシ基、アミノ基、力ルバモイル基等の窒素 原子を含有する基;塩素原子、臭素原子等のハロゲン原子;水酸基;等を例示するこ とがでさる。 In the above formula (I), X represents a hydrolyzable group or hydroxyl group bonded to M. Specifically, alkoxy having 1 to 12 carbon atoms such as methoxy group, ethoxy group, n-propoxy group, isopropoxy group, n-butoxy group, sec-butoxy group, t-butoxy group, n-pentyloxy group, etc. A group containing a nitrogen atom such as a hydroxyimino group, a hydroxyamino group, an enoxy group, an amino group, or a strong rubamoyl group; a halogen atom such as a chlorine atom or a bromine atom; a hydroxyl group; Monkey.
[0039] 上記式 (I)中、 a及び bはそれぞれ独立して、 0から m (mは金属原子の原子価を表 す。)の整数を表す (ただし、 a+b=m) 0前記式 (I)で表される化合物は、分子内に 加水分解性基及び Z又は水酸基を合計で 2以上有する化合物であることから、前記 式 (I)において、 bが 2以上の化合物; bが 1であって、加水分解性基を有する Rが 1以 上である化合物; bが 0であって、加水分解性基を有する Rが 2以上である化合物;を ί列示することができる。 前記式 (I)で表される化合物の具体例としては、メチルトリメトキシシラン、メチルトリ エトキシシラン、ェチルトリメトキシシラン、ェチルトリエトキシシラン、プロピルトリメトキ シシラン、プロピノレトリエトキシシラン、テトラメトキシシラン、テトラエトキシシラン、テトラ n プロポキシシラン、テトライソプロポキシシラン、 13 (3, 4 エポキシシクロへ [0039] In the above formula (I), a and b each independently represent an integer of 0 to m (m represents a valence of a metal atom) (where a + b = m) 0 Since the compound represented by the formula (I) is a compound having a total of 2 or more hydrolyzable groups and Z or hydroxyl groups in the molecule, in the formula (I), b is a compound having 2 or more; 1 and R having a hydrolyzable group is 1 or more; B is 0 and R having a hydrolyzable group is 2 or more; Specific examples of the compound represented by the formula (I) include methyltrimethoxysilane, methyltriethoxysilane, etyltrimethoxysilane, etyltriethoxysilane, propyltrimethoxysilane, propinoretriethoxysilane, tetramethoxy. Silane, tetraethoxysilane, tetra-n-propoxysilane, tetraisopropoxysilane, 13 (3,4 epoxycyclo
3—グリシドキシプロピルトリメトキシシラン、ベンジルトリエトキシシラン、ァリルトリエト キシシラン、ビニルメチルジァセトキシシラン、 3—メタクリロキシプロピルトリメトキシシ ラン、 3—メタクリロキシプロピルトリエトキシシラン、 3—アタリロキシプロピルトリメトキシ シラン、 2 クロ口ェチルトリエトキシシラン、 4 アミノブチルトリエトキシシラン、 3 ァ ミノプロピルトリエトキシシラン、 3—ァミノプロピルトリメトキシシラン等のシランアルコキ シド;テトラメトキシゲルマニウム、テトラエトキシゲルマニウム等のゲルマニウムアルコ キシド;テトラ一 n—プロポキシチタン、テトライソプロポキシチタン、テトラ一 n—ブトキ シチタン、テトラー sec ブトキシチタン、テトラー t ブトキシチタン等のチタンアルコ キシド;テトラー n—プロポキシジルコニウム、テトライソプロポキシジノレコ-ゥム、テトラ —n—ブトキシジルコニウム、テトラー sec ブトキシジルコニウム、テトラー t—ブトキシ ジルコニウム等のジルコニウムアルコキシド;トリエトキシアルミニウム、トリ—n—プロボ キシアルミニウム、トリイソプロポキシアルミニウム、トリ— n—ブトキシアルミニウム、トリ sec ブトキシアルミニウム、トリー t ブトキシアルミニウム等のアルミニウムアルコ キシド;テトラクロロシラン、テトラブロモシラン、ジメチルジクロロシラン、ベンジルトリク ロロシラン、 t—ブチルフエニルジクロロシラン、 3—クロ口プロピルトリクロロシラン、 8- ブロモォクチルトリクロロシラン、 3—ブロモプロピルトリクロロシラン、(3, 3, 3—トリフ ルォロプロピル)ジクロロシラン、(3, 3, 3—トリフルォロプロピル)トリクロロシラン、クロ ロメチルトリクロロシラン、ァリルトリクロロシラン、 3—アタリロキシプロピルトリクロロシラ ン等のハロゲノシラン;テトラキス(ジェチルァミノ)シラン等のアミノシラン;ビュルメチ ルビス (メチルェチルケトキシミン)シラン等の他のシラン化合物; 3, 3, 3—トリフルォ 口プロピルジメトキシヒドロキシシラン、 3, 3, 3—トリフルォロプロピルメトキシジヒドロキ シシラン、オタチノレエトキシジヒドロキシシラン等のヒドロキシシラン;等を挙げることが できる。 [0041] これらの中でも、シランアルコキシド、ゲルマニウムアルコキシド、チタンアルコキシド 、ジルコニウムアルコキシド及びアルミニウムアルコキシド等の金属アルコキシドが好 ましぐシランアルコキシド、チタンアルコキシド又はジルコニウムアルコキシドがより好 ましぐチタンアルコキシドが特に好ましい。 3-Glycidoxypropyltrimethoxysilane, benzyltriethoxysilane, allyltriethoxysilane, vinylmethyldiacetoxysilane, 3-methacryloxypropyltrimethoxysilane, 3-methacryloxypropyltriethoxysilane, 3-ataryloxypropyl Silane alkoxides such as trimethoxysilane, 2-chloroethyltriethoxysilane, 4-aminobutyltriethoxysilane, 3-aminopropyltriethoxysilane, 3-aminopropyltrimethoxysilane; tetramethoxygermanium, tetraethoxygermanium, etc. Germanium alkoxides; titanium alcohols such as tetra-n-propoxy titanium, tetra-isopropoxy titanium, tetra-n-butoxy titanium, tetra-sec butoxy titanium, tetra-butoxy titanium Zirconium alkoxides such as tetra-n-propoxyzirconium, tetraisopropoxyzirconium, tetra-n-butoxyzirconium, tetra-sec butoxyzirconium, tetra-t-butoxyzirconium; triethoxyaluminum, tri- n -propoxyaluminum , Triisopropoxyaluminum, tri-n-butoxyaluminum, trisec butoxyaluminum, tri-butoxyaluminum and other aluminum alkoxides; tetrachlorosilane, tetrabromosilane, dimethyldichlorosilane, benzyltrichlorosilane, t-butylphenyldichlorosilane , 3-chloropropyl chlorotrichlorosilane, 8-bromooctyltrichlorosilane, 3-bromopropyltrichlorosilane, (3, 3, 3-trifluor Halogenosilanes such as (ropropyl) dichlorosilane, (3,3,3-trifluoropropyl) trichlorosilane, chloromethyltrichlorosilane, allyltrichlorosilane, 3-ataryloxypropyltrichlorosilane; tetrakis (jetylamino) silane, etc. Other silane compounds such as butylmethylbis (methylethylketoximine) silane; 3, 3, 3-trifluoropropyl methoxydimethoxyhydroxysilane, 3, 3, 3-trifluoropropylmethoxydihydroxysilane, otachinole And hydroxysilanes such as ethoxydihydroxysilane. Among these, metal alkoxides such as silane alkoxide, germanium alkoxide, titanium alkoxide, zirconium alkoxide, and aluminum alkoxide are preferable, and silane alkoxide, titanium alkoxide, and zirconium alkoxide are more preferable.
[0042] 上記の加水分解性基及び Z又は水酸基を合計で 1以上有する金属キレート化合 物としては、加水分解性基及び Z又は水酸基を合計で 1以上有し、かつ、キレートイ匕 合物が結合してなるものであって、加水分解して両親媒性の金属酸ィ匕物ナノ粒子を 製造できるものであれば特に制限されるものではなぐ加水分解性基としては、前記 加水分解性基及び Z又は水酸基を合計で 2以上有する金属化合物のところで例示 したちのと同じちのを挙げることがでさる。  [0042] The above-mentioned metal chelate compound having one or more hydrolyzable groups and one or more Z or hydroxyl groups has one or more hydrolyzable groups and one or more Z or hydroxyl groups, and the chelate compound is bonded. The hydrolyzable group is not particularly limited as long as it can be hydrolyzed to produce amphiphilic metal oxide nanoparticles. Examples of the hydrolyzable group include the hydrolyzable group and In the case of metal compounds having a total of two or more Z or hydroxyl groups, the same examples can be mentioned.
[0043] キレート化合物としては、ァセト酢酸メチル、ァセト酢酸ェチル、ァセト酢酸 n—プ 口ピル、ァセト酢酸イソプロピル、ァセト酢酸—n—ブチル、ァセト酢酸—sec ブチル 、ァセト酢酸 t ブチル等の j8—ケトエステル類;ァセチルアセトン、へキサン 2, 4ージオン、ヘプタン 2, 4 ジオン、ヘプタン 3, 5 ジオン、オクタン 2, 4 ジ オン、ノナン一 2, 4 ジオン、 5—メチルーへキサン一 2, 4 ジオン等の j8—ジケト ン類;シユウ酸、マロン酸、コハク酸、グルタル酸、アジピン酸、ピメリン酸、スベリン酸 、ァゼライン酸、セバシン酸等の飽和脂肪族ジカルボン酸類;エチレングリコール等 のグリコール類;ォキシ酢酸等のグリコール酸類;エチレンジァミン四酢酸(EDTA) 及びそのナトリウム塩、エチレンジァミン、 1, 3 プロパンジァミン、ジエチレントリアミ ン、ペンタメチルジェチレントリァミン、へキサメチルトリエチレンテトラミン、トリス [2— ( ジメチルァミノ)ェチル]ァミン、トリ(ピリジ -ルメチル)ァミン等の含窒素化合物;フラ ンカノレボン酸、チ才フェン力ノレボン酸、ニコチン酸、イソニコチン酸、フエナント口リン、 ジフエナント口リン、置換フエナント口リン、 2, 2' , 6' , 2,,一ターピリジン、ピリジンイミ ン、架橋脂肪族ジァミン、 4, 4,ージ(5 ノエル)—2, 2,—ビビリジン、 O, S, Se, T eの配位したビビリジン、アルキルイミノビリジン、アルキルビビリジニルァミン、アルキ ル置換トリピリジン、ジ(アルキルァミノ)アルキルピリジン、エチレンジアミンジピリジン 、その他の複素環化合物; 2—メルカプトエタノール等のメルカプトアルコール類;エタ ンジチオール等のジチオール類; 2—メルカプトェチルァミン等のメルカプトアミン類; 2, 4-ペンタンジチオン等のジチオケトン類;等の硫黄含有化合物等を挙げることが できる。 [0043] Examples of chelate compounds include j8-ketoesters such as methyl acetoacetate, ethyl acetoacetate, acetoacetate n-propyl, acetoacetate isopropyl, acetoacetate-n-butyl, acetoacetate-sec butyl, acetoacetate tbutyl Acetylacetone, hexane 2,4-dione, heptane 2,4 dione, heptane 3,5 dione, octane 2,4 dione, nonane 1,2,4 dione, 5-methyl-hexane 1,2,4 dione, etc. J8-diketons; oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid and other saturated aliphatic dicarboxylic acids; ethylene glycol and other glycols; oxyacetic acid Glycolic acids such as ethylenediamine tetraacetic acid (EDTA) and its sodium salt, ethylenediamine, 1,3 propanediamin, diethyl Nitrogen-containing compounds such as lentriamin, pentamethyljetylenetriamine, hexamethyltriethylenetetramine, tris [2- (dimethylamino) ethyl] amine, tri (pyridyl-methyl) amine; , Nicotinic acid, isonicotinic acid, phenanthorin, diphenantorin, substituted phenantorin, 2, 2 ', 6', 2, monoterpyridine, pyridineimine, cross-linked aliphatic diamine, 4, 4, 5 Noel) -2, 2, 2-biviridine, O, S, Se, Te coordinated biviridine, alkyliminoviridine, alkylbibilidinylamine, alkyl-substituted tripyridines, di (alkylamino) alkylpyridines, ethylenediaminedipyridine , Other heterocyclic compounds; mercapto alcohols such as 2-mercaptoethanol; Dithiols such as ethanedithiol; mercaptoamines such as 2-mercaptoethylamine; And sulfur-containing compounds such as dithioketones such as 2,4-pentanedithione;
[0044] 加水分解性基及び Z又は水酸基を合計で 1以上有する金属キレート化合物として 、ジエトキシビスァセチノレアセトナートチタン、ジイソプロポキシビスァセチノレアセトナ ートチタン、ジノルマルプロポキシビスァセチルァセトナートチタン、ジノルマルブトキ シビスァセチルァセトナートチタン、ジエトキシビスァセチルァセトナートジルコニウム 、ジイソプロポキシビスァセチノレアセトナートジノレコニゥム、ジノノレマノレプロポキシビス ァセチルァセトナートジルコニウム、ジノルマルブトキシビスァセチルァセトナートジル コニゥム、ジェトキシァセチノレアセトナートァノレミニゥム、ジイソプロポキシァセチノレア セトナートアルミニウム、ジノルマルプロポキシァセチルァセトナートアルミニウム、ジノ ルマルブトキシァセチルァセトナートアルミニウム、エトキシビス(ァセチルァセトナート )アルミニウム、イソプロポキシビス(ァセチルァセトナート)アルミニウム、ノルマルプロ ポキシビス(ァセチルァセトナート)アルミニウム、ノルマルブトキシビス(ァセチルァセ トナート)アルミニウム等を具体的に例示することができ、中でも、ジイソプロボキシビ スァセチルァセトナートチタンを好適に挙げることができる。  [0044] As a metal chelate compound having a total of 1 or more hydrolyzable group and Z or hydroxyl group, diethoxybisacetinoreacetonate titanium, diisopropoxybisacetinoreacetonate titanium, dinormalpropoxybisacetylene Setonate Titanium, Dinormal Butoxy Bisacetylacetonate Titanium, Diethoxybisacetyl Casetonate Zirconium, Diisopropoxybiscetinoreacetonate Zinoreconium, Dinoremanole Propoxybis Acetylacetonate Zirconium, Di-N-Butoxybisacetyl cetate tozyl corn, Jetoxy cetinoreacetonato anoreminium, Diisopropoxy cetinorea Setonate Aluminum, Di-N-propoxy cetylacetonate Aluminum, Dinormal Butoxyacetyl acetonate aluminum, ethoxy bis (acetyl cetate) aluminum, isopropoxy bis (acetyl cettonate) aluminum, normal propoxy bis (acetyl cettonate) aluminum, normal butoxy bis (acetyl acetonate) aluminum In particular, diisopropoxybisacetyl cetate titanium can be mentioned as a preferred example.
[0045] 加水分解性基及び Z又は水酸基を合計で 1以上有する金属キレート化合物は、例 えば、加水分解性基及び Z又は水酸基を合計で 1以上有する金属化合物に、所定 量のキレートイ匕合物を添加し攪拌することにより得ることができる。得られる金属キレ 一トイ匕合物は単離することもできるが、そのまま次の加水分解及び縮重合反応に供 することちでさる。 [0045] The metal chelate compound having one or more hydrolyzable groups and Z or hydroxyl groups in total includes, for example, a predetermined amount of a chelate compound in a metal compound having one or more hydrolyzable groups and Z or hydroxyl groups in total. It can obtain by adding and stirring. The resulting metal-cleared toy compound can be isolated, but can be used in the subsequent hydrolysis and polycondensation reaction as it is.
[0046] 前記の加水分解生成物は、加水分解性基及び Z又は水酸基を合計で 2以上有す る金属化合物、加水分解性基及び Z又は水酸基を合計で 1以上有する金属キレート 化合物からなる群力 選ばれる少なくとも一種 (以下、これらをまとめて「金属化合物 等」という。)の 1モルに対して、 1モル以上、好ましくは 5モル以上、より好ましくは 10 モル以上の水を用いて加水分解して製造することができる。この場合、加水分解生 成物は完全加水分解生成物であっても、部分加水分解生成物であってもよい。これ ら加水分解生成物の中でも、加水分解性基及び Z又は水酸基を合計で 1以上有す る金属キレート化合物の加水分解生成物が特に好まし 、。上記加水分解生成物の 調製法としては、 1)金属キレートイ匕合物を水に滴下し加水分解を行い、抗菌成分の アルコール溶液と混合し、防カビ溶液を得る方法、 2)金属キレート化合物をアルコー ル溶媒に加えてから、水を加えて加水分解を行い、そののち、抗菌成分のアルコー ル溶液と混合し、防カビ溶液を得る方法、 3)抗菌成分のアルコール溶液に金属キレ ート化合物を加え、そこに水を加えて加水分解を行い、防カビ溶液を得る方法等を 挙げることができるが、上記 3)の調製方法が特に好ましぐまた、調製は 0°C〜室温 で行うことが好ましぐ使用する溶媒としてはエタノール、プロパノール等のアルコー ル系溶媒が好ましい。 [0046] The hydrolysis product is a group consisting of a metal compound having a total of 2 or more hydrolyzable groups and Z or hydroxyl groups, and a metal chelate compound having a total of 1 or more hydrolyzable groups and Z or hydroxyl groups. Hydrolysis with 1 mol or more, preferably 5 mol or more, more preferably 10 mol or more of water with respect to 1 mol of at least one selected (hereinafter collectively referred to as “metal compound etc.”). Can be manufactured. In this case, the hydrolysis product may be a complete hydrolysis product or a partial hydrolysis product. Among these hydrolysis products, a hydrolysis product of a metal chelate compound having a total of 1 or more hydrolyzable groups and Z or hydroxyl groups is particularly preferred. Of the hydrolysis product As preparation methods, 1) a metal chelate compound is dropped into water and hydrolyzed and mixed with an alcohol solution of an antibacterial component to obtain an antifungal solution, and 2) a metal chelate compound is added to an alcohol solvent. Then, water is added to hydrolyze, and then mixed with the alcohol solution of the antibacterial component to obtain an antifungal solution. 3) Add the metal chelate compound to the alcohol solution of the antibacterial component, and add water to it. The method described in 3) is particularly preferred, and the preparation is preferably carried out at 0 ° C to room temperature. As the solvent to be used, an alcohol solvent such as ethanol or propanol is preferable.
[0047] 前記の加水分解生成物の製造時において、水で加水分解する際又は加水分解後 には、酸、塩基及び Z又は分散安定化剤を添加することもできる。添加する酸として は、例えば、塩酸、硝酸、ホウ酸、ホウフッ化水素酸等の鉱酸、酢酸、ギ酸、シユウ酸 、炭酸、トリフルォロ酢酸、 p—トルエンスルホン酸、メタンスルホン酸等の有機酸等; ジフエ-ルョード-ゥムへキサフノレオ口ホスフェート、トリフエ二ノレホスホ-ゥムへキサ フルォロホスフェート等の光照射によって酸を発生する光酸発生剤;を挙げることが でき、塩基としては、例えば、トリエタノールァミン、トリェチルァミン、 1, 8—ジァザビ シクロ [5. 4. 0]— 7—ゥンデセン、アンモニア、ジメチルホルムアミド、ホスフィン等を 挙げることができる。  [0047] In the production of the hydrolysis product, an acid, a base and Z or a dispersion stabilizer may be added when hydrolyzing with water or after hydrolysis. Examples of acids to be added include mineral acids such as hydrochloric acid, nitric acid, boric acid and borohydrofluoric acid, organic acids such as acetic acid, formic acid, oxalic acid, carbonic acid, trifluoroacetic acid, p-toluenesulfonic acid and methanesulfonic acid. A photoacid generator that generates an acid upon irradiation with light, such as diphenyl-sulfo-hexoxano-reno-oral phosphate and triphenylenophospho-hexafluorophosphate; Examples include triethanolamine, triethylamine, 1,8-diazabicyclo [5.4.0] -7-undecene, ammonia, dimethylformamide, and phosphine.
[0048] 両親媒性の金属酸化物ナノ粒子の粒径としては、 0. 8ηπ!〜 100nm、好ましくは 1 ηπ!〜 30nm、より好ましくは 3ηπ!〜 lOnmのナノ粒子力 均一分散性に優れ、 20〜 50nmの薄 ヽ膜厚の塗膜を形成することができ、抗菌成分等と併用すると抗菌成分 等と均一混合体を形成して抗菌成分等が微細粒子として析出し、大きな結晶状に析 出しない点で好ましい。また、両親媒性の金属酸ィ匕物ナノ粒子としては、両親媒性の 酸ィ匕チタンナノ粒子力 均一な粒径のナノ粒子を形成しうる点で好ま ヽ。  [0048] The particle size of the amphiphilic metal oxide nanoparticles is 0.8ηπ! ~ 100nm, preferably 1 ηπ! ~ 30nm, more preferably 3ηπ! -LOnm nanoparticle strength Excellent dispersibility, can form a thin film with a thickness of 20-50 nm, and when used in combination with antibacterial components, forms a uniform mixture with antibacterial components, etc. Is preferable in that it precipitates as fine particles and does not precipitate into large crystals. In addition, the amphiphilic metal oxide nanoparticles are preferable in that they can form nanoparticles with a uniform particle size of amphiphilic acid titanium nanoparticles.
[0049] 本発明の抗菌剤組成物に両親媒性の金属酸化物ナノ粒子を含有させる場合の、 該金属酸化物ナノ粒子の含有量は、抗菌剤組成物全量に対して 0. 01〜10重量% 、特に 0. 1〜2重量%であることが、透明で柔軟な薄膜を形成する上で好ましぐまた 、抗菌成分の含有量が酸化チタンナノ粒子等の金属酸化物ナノ粒子の含有量 (重量 )の 0. 01〜5倍、特に 0. 1〜2倍であることが、抗菌成分と酸ィ匕チタンナノ粒子等の 金属酸ィ匕物ナノ粒子との均一な混合体を形成しうる点で好ましい。 [0049] When the antibacterial agent composition of the present invention contains amphiphilic metal oxide nanoparticles, the content of the metal oxide nanoparticles is 0.01 to 10 with respect to the total amount of the antibacterial agent composition. % By weight, particularly 0.1 to 2% by weight, is preferable for forming a transparent and flexible thin film. Also, the content of the antibacterial component is the content of metal oxide nanoparticles such as titanium oxide nanoparticles. (Weight) is 0.01-5 times, especially 0.1-2 times, such as antibacterial components and acid titanium nanoparticles It is preferable at the point which can form a uniform mixture with a metal oxide nanoparticle.
[0050] 本発明の菌発生防止方法としては、本発明の抗菌剤組成物を、窓のゴムパッキン; 浴室内の天井、壁面、排水口付近、タイルの目地;洗面台;等のカビなどの生え易い 箇所に塗布する方法であれば特に制限されない。  [0050] As a method for preventing the generation of bacteria according to the present invention, the antibacterial agent composition of the present invention is used for rubber packing of windows; ceilings in bathrooms, wall surfaces, drain outlets, tile joints; washstands; If it is the method of apply | coating to the location which grows easily, there will be no restriction | limiting in particular.
本発明の抗菌剤組成物は、防力ビ剤を有効成分とする組成物の場合には、窓のゴ ムパッキン;浴室の天井、壁面、排水口付近、タイルの目地;洗面台等のカビの生え やすい箇所に塗布して、カビの発生を防止する目的で使用される。抗細菌 '抗酵母 剤を有効成分とする組成物の場合には、トイレの床や壁、便器の内壁面や外壁面に 塗布して、飛散した尿が腐敗して悪臭を発生することを防止したり、あるいは、生ごみ の集積場所の周辺の床に塗布して、生ごみから流出する液体が腐敗し悪臭を発生 することを防止する等、細菌、酵母の繁殖による臭気や不衛生状態を防止する目的 で使用される。  When the antibacterial agent composition of the present invention is a composition containing a antibacterial agent as an active ingredient, the rubber packing of the window; the ceiling of the bathroom, the wall surface, the vicinity of the drainage, the joint of the tile; It is used for the purpose of preventing the occurrence of mold by applying it to the place where it tends to grow. In the case of a composition containing an antibacterial 'anti-yeast agent' as an active ingredient, it is applied to the toilet floor and walls and the inner and outer wall surfaces of the toilet to prevent the scattered urine from decaying and generating odors. Or, it can be applied to the floor around the garbage collection area to prevent the liquid flowing out from the garbage from decaying and producing odors. It is used for the purpose of
塗布方法としては、具体的には、スプレー吹き付け法、エアゾール吹き付け法、印 刷法、シート成形法、ディップコーティング法、スピンコーティング法、バーコ一ター法 、メイヤーバー法、刷毛塗装方法、ローラー塗装方法等を例示することができるが、ス プレー吹き付け法が好ましい。本発明の抗菌剤組成物により形成される被膜の厚さ は特に制限されないが、好ましくは 5〜500nmの範囲内、より好ましくは 20〜300n mの範囲内とすることができる。  Specifically, the spraying method, the aerosol spraying method, the printing method, the sheet forming method, the dip coating method, the spin coating method, the bar coater method, the Mayer bar method, the brush coating method, and the roller coating method. The spray spraying method is preferable. The thickness of the film formed by the antibacterial agent composition of the present invention is not particularly limited, but can be preferably in the range of 5 to 500 nm, more preferably in the range of 20 to 300 nm.
[0051] 本発明のスプレー型抗菌剤は、本発明の抗菌剤組成物が容器に収容されてなるも のであれば特に制限されず、該容器としては内容物をスプレーしうる容器であれば特 に制限されない。 [0051] The spray-type antibacterial agent of the present invention is not particularly limited as long as the antibacterial agent composition of the present invention is contained in a container, and the container is not particularly limited as long as it can spray contents. Not limited to.
[0052] 以下、実施例により本発明をより具体的に説明するが、本発明の技術的範囲はこ れらの例示に限定されるものではない。  [0052] Hereinafter, the present invention will be described more specifically by way of examples. However, the technical scope of the present invention is not limited to these examples.
実施例  Example
[0053] 〔実施例 A〕 [Example A]
1.疎水性部位を有する有機ポリマーの調製  1. Preparation of organic polymers with hydrophobic sites
(1)スチレン無水マレイン酸共重合体の合成  (1) Synthesis of styrene maleic anhydride copolymer
500mLナスフラスコ中に、スチレン 16. 68g (0. 16mol)、無水マレイン酸 17. 7g ( 0. 18mol)、ァゾビスイソブチ口-トリル (AIBN) l. 106g (6. 73mol)、テトラヒドロフ ラン (以下、「丁1^」とぃぅ)20011^を添加し、混合して溶解させ、脱気後 N置換し 60 In a 500 mL eggplant flask, styrene 16.68 g (0.16 mol), maleic anhydride 17.7 g ( 0.18mol), azobisisobuty-tolyl-tolyl (AIBN) l. 106g (6. 73mol), tetrahydrofuran (hereinafter referred to as "Ding 1 ^" and "ぅ") 20011 ^ are added, mixed and dissolved, and deaerated. After N substitution 60
2  2
°Cで 6時間反応させた。反応液を放冷後、 THF—メタノール溶媒で再沈殿させ、乾 燥することでスチレン無水マレイン酸共重合体を 39. 03g得た。回収率は 87%であ つた。得られた重合体の分子量を GPCにより測定した。 GPCは溶媒として THFを用 い、ポリスチレンを標準物質として用いた。その結果、数平均分子量 11000、重量平 均分子量 82000、メインピーク 19000であった。この榭脂を以下「榭脂 A」とする。  The reaction was performed at ° C for 6 hours. The reaction solution was allowed to cool, reprecipitated with THF-methanol solvent, and dried to obtain 39.03 g of a styrene maleic anhydride copolymer. The recovery rate was 87%. The molecular weight of the obtained polymer was measured by GPC. GPC used THF as a solvent and polystyrene as a standard substance. As a result, the number average molecular weight was 11,000, the weight average molecular weight was 82000, and the main peak was 19000. This rosin is hereinafter referred to as “Resin A”.
[0054] (2)スチレン無水マレイン酸共重合体加水分解物の合成  [0054] (2) Synthesis of styrene maleic anhydride copolymer hydrolyzate
500mLナスフラスコ中に、先に得られた榭脂 A14. 8gをアセトン lOOmLに溶解さ せ、該溶液中に、室温で 1N水酸ィ匕ナトリウム水溶液 150mLを 1時間かけて滴下した 。その後 1時間加熱環流を行い、放冷後 2N塩酸を pHが 3になるまでカ卩え、生成した 沈殿物を濾別、水洗し乾燥させることでスチレンマレイン酸共重合体 13. 61gを得た 。収率は 84%であった。この榭脂を以下「榭脂 a」とする。  In a 500 mL eggplant flask, 14.8 g of the previously obtained rosin A was dissolved in 10 mL of acetone, and 150 mL of 1N sodium hydroxide aqueous solution was added dropwise to the solution at room temperature over 1 hour. The mixture was then heated to reflux for 1 hour, allowed to cool, and then 2N hydrochloric acid was added until the pH reached 3. The resulting precipitate was filtered, washed with water and dried to obtain 13.61 g of a styrene maleic acid copolymer. . The yield was 84%. This rosin is hereinafter referred to as “Resin a”.
[0055] 上記(1)及び(2)で得られた榭脂 A及び榭脂 aについて13 C— NMR (single pulse d ecoupled without NOE法)により分析を行い、得られた榭脂 A及び榭脂 aにおけるス チレンと無水マレイン酸の共重合糸且成比が 1対 1であること、及び、榭脂 aには未反応 の無水マレイン酸部位が無 、ことを確認した。 [0055] The fat A and the fat a obtained in the above (1) and (2) were analyzed by 13 C-NMR (single pulse decoupled without NOE method). It was confirmed that the copolymer yarn ratio of styrene and maleic anhydride in a was 1: 1, and that there was no unreacted maleic anhydride site in resin a.
榭脂 Aの13 C— NMRチャートを図 1に、榭脂 aの13 C— NMRチャートを図 2に示す。 また、榭脂 Aの IR ^ベクトルを図 3に、榭脂 aの IR ^ベクトルを図 4に示す。 Fig. 1 shows the 13 C-NMR chart of rosin A, and Fig. 2 shows the 13 C-NMR chart of rosin a. Figure 3 shows the IR ^ vector of rosin A, and Figure 4 shows the IR ^ vector of rosin a.
[0056] 2.抗菌剤組成物の調製と成膜 [0056] 2. Preparation and film formation of antibacterial agent composition
以下の表 1の実施例 1〜2及び比較例 1に示された組成の組成物を調製した。実施 例 1〜2及び比較例 1に示された組成物は、エタノール水溶液以外の成分をエタノー ル水溶液中に添加、混合し、 30分以上撹拌することにより調製した。また、比較例 1 については、 AP社市販品を用いた。  The compositions having the compositions shown in Examples 1-2 and Comparative Example 1 in Table 1 below were prepared. The compositions shown in Examples 1-2 and Comparative Example 1 were prepared by adding and mixing components other than the ethanol aqueous solution in the ethanol aqueous solution and stirring for 30 minutes or more. For Comparative Example 1, a commercial product from AP was used.
[0057] [表 1] 防力ビ試験用の組成物サンプルとその組成 [0057] [Table 1] Composition sample for strength test and its composition
Figure imgf000023_0001
Figure imgf000023_0001
PAA:ポリアクリル酸 PAA: Polyacrylic acid
[0058] 塩化ビニル基板 (アタリサンデー社製、透明硬質塩化ビニール板、厚み 0. 5mm、 ヘイズ率 1. 0〜1. 3)を用意し、バーコ一ター(自動塗工装置 PI— 1210及び ROD No.5のバー;テスター産業株式会社製)を用いて、実施例 1の組成物を前記塩化ビ -ル基板上に塗布した。塗布後室温で 24時間乾燥させて成膜させたものを成膜サ ンプルとして各種評価を行つた。  [0058] A vinyl chloride substrate (made by Atari Sunday, transparent hard vinyl chloride plate, thickness 0.5mm, haze ratio 1.0 to 1.3) is prepared, and a bar coater (automatic coating equipment PI-1210 and ROD The composition of Example 1 was applied onto the vinyl chloride substrate using No. 5 bar (manufactured by Tester Sangyo Co., Ltd.). Various evaluations were performed using the samples formed by drying at room temperature for 24 hours after coating as film formation samples.
実施例 1の組成物に代えて、実施例 2、及び比較例 1のいずれかの組成物を用いて 同様の操作を行 ヽ、それぞれにつ!/ヽて成膜サンプルを得た。  The same operation was carried out using the composition of Example 2 and Comparative Example 1 in place of the composition of Example 1, and a film-forming sample was obtained for each.
[0059] 3.ヘイズ率の測定 [0059] 3. Measurement of haze ratio
上記 2.で得られた成膜サンプルの膜の透明性を濁度計(日本電色工業株式会社 製)で測定した。また、ブランクとして、塩ィ匕ビニル基板のみの透明性も同様に測定し た。その結果を表 2に示す。  The transparency of the film of the film formation sample obtained in 2. above was measured with a turbidimeter (manufactured by Nippon Denshoku Industries Co., Ltd.). As a blank, the transparency of only a vinyl chloride substrate was also measured. The results are shown in Table 2.
[0060] [表 2] 防力ビ試験サンプルとヘイズ率 [0060] [Table 2] Strength test sample and haze ratio
Figure imgf000023_0002
Figure imgf000023_0002
[0061] 表 2の結果によって、本発明の抗菌剤組成物である実施例 1〜2は、有機ポリマー は含まれているものの、それが疎水性部位を有していない比較例 1と比較して、ヘイ ズ率が低ぐ透明性が高いことが示された。 [0061] According to the results in Table 2, Examples 1 and 2 which are antibacterial agent compositions of the present invention are compared with Comparative Example 1 which contains an organic polymer but does not have a hydrophobic site. Thus, it was shown that the haze ratio is low and the transparency is high.
[0062] 4.防カビ試験 上記 2.と同様の方法により得られた成膜サンプルを、 3cm X 7. 5cmの大きさに裁 断して試験片を得た。シャーレに 50mlのイオン交換水を入れ、そこに試験片を表 3 に記載の所定時間(0、 1、 5、 10、 20、 40、 60分)浸漬した。浸漬後、室温で 24時間 乾燥した。その後、試験片の表面のカビの有無を 4段階で評価した。その結果を表 3 に示す。 [0062] 4. Mold prevention test A film sample obtained by the same method as in 2 above was cut into a size of 3 cm × 7.5 cm to obtain a test piece. 50 ml of ion exchange water was put into the petri dish, and the test piece was immersed in the petri dish for a predetermined time (0, 1, 5, 10, 20, 40, 60 minutes) shown in Table 3. After soaking, it was dried at room temperature for 24 hours. Then, the presence or absence of mold on the surface of the test piece was evaluated in four stages. The results are shown in Table 3.
[0063] [表 3] [0063] [Table 3]
防力ビ試験結果  Defense force test results
Figure imgf000024_0002
Figure imgf000024_0002
[0064] :カビ無し [0064]: No mold
士 :菌糸のみ (実用上問題なし)  : Mycelium only (no problem in practical use)
+ :カビ発生  +: Mold generation
+ +:ブランクと同等のカビ発生  + +: Mold equivalent to blank
[0065] 実施例 1〜2は、比較例 1と比較して、優れた抗カビ効果の持続性を有して 、ること は明らかである。 [0065] It is clear that Examples 1 and 2 have superior antifungal durability compared to Comparative Example 1.
[0066] 5.樹脂 aと TBZの最適比率の検討 [0066] 5. Examination of optimal ratio of resin a and TBZ
榭脂 aと TBZの最適比率を検討するために、榭脂 aと TBZの含有重量の比率を表 4 に示すように様々に変化させたサンプルを、上記 2.と同様の方法により作製した。な お、これらの成膜サンプルを作製する際に用いた抗菌剤組成物における TBZ濃度 は 0.
Figure imgf000024_0001
各成分を 50wt%EtOH水溶液に溶解させて用いた。
In order to study the optimum ratio of rosin a and TBZ, samples were prepared by the same method as in 2. above, with the ratio of the weight of cocoa a and TBZ varied as shown in Table 4. The TBZ concentration in the antibacterial agent composition used for preparing these film samples was 0.
Figure imgf000024_0001
Each component was used by dissolving in 50 wt% EtOH aqueous solution.
[0067] 得られたこれらの成膜サンプルについて上記 3.と同様にヘイズ率を測定した。そ の結果を表 4に示す。なお、ブランクとして、塩ィ匕ビニル基板のみのヘイズ率も測定し たところ、 1. 09であった。 [0067] The haze ratios of these obtained film formation samples were measured in the same manner as in 3. above. The results are shown in Table 4. As a blank, the haze ratio of only the vinyl chloride vinyl substrate was measured and found to be 1.09.
[0068] [表 4] 樹脂 a - T B Z組成最適化検討 [0068] [Table 4] Resin a-TBZ composition optimization study
Figure imgf000025_0001
Figure imgf000025_0001
[0069] また、得られたそれぞれの成膜サンプルにつ L、て、水滴を用いて接触角の測定を 行った。接触角の測定は、接触角計 (協和界面科学株式会社製、「Drop Master 700」)により行った。それぞれの成膜サンプルについて測定した接触角を表 4に示 す。この結果から、榭脂 a: TBZの含有量比率が 3:1の成膜サンプル力 最も高い疎 水性を示すことが分力 た。また、ブランクとして塩ィ匕ビエル基板の接触角を測定した ところ 65.8° であった。 [0069] Further, for each of the obtained film formation samples, a contact angle was measured using water droplets. The contact angle was measured with a contact angle meter (“Drop Master 700” manufactured by Kyowa Interface Science Co., Ltd.). Table 4 shows the measured contact angles for each film sample. From this result, it was found that the film forming sample strength with a 3: 1 ratio of resin a: TBZ showed the highest hydrophobicity. In addition, the contact angle of the salt-metal substrate as a blank was measured and found to be 65.8 °.
なお、榭脂 aのカルボキシル基の数は、榭脂 a:TBZ 3: 1であっても、 TBZ1分子 に対して過剰(モル比でカルボキシル基 6に対して TBZ1)であるが、榭脂 aの添加量 を増やすにつれてこの過剰のカルボキシル基が親水化に寄与しているものと考えら れる。  The number of carboxyl groups of rosin a is excessive with respect to TBZ1 molecules (TBZ1 with respect to carboxylic group 6 in molar ratio) even if rosin a: TBZ 3: 1. It is considered that this excess carboxyl group contributes to hydrophilization as the addition amount of is increased.
[0070] 〔実施例 B〕  [Example B]
1.疎水性部位を有する有機ポリマーの調製  1. Preparation of organic polymers with hydrophobic sites
市販されて 、るスチレン無水マレイン酸共重合体を入手し、実施例 Aと同様の条件 で GPCにより分子量の測定を行った。それぞれの分子量、共重合比を表 5に示す。  A commercially available styrene maleic anhydride copolymer was obtained, and the molecular weight was measured by GPC under the same conditions as in Example A. Table 5 shows the molecular weight and copolymerization ratio of each.
[表 5] 数平均分子 重量平均分子 メインピー 共重合比 [Table 5] Number average molecule Weight average molecule Main pea copolymerization ratio
.  .
ク (スチレン  (Styrene
/無水マレイン酸) 榭脂 B 2800 4500 4400 1/1 樹脂 C 2800 5000 4800 1/1 樹脂 D 4300 10000 8800 1/1 樹脂 E 23000 1 34000 53000 1/1 樹脂 F 30000 217000 58000 1/1 榭脂 G 3200 5900 5500 2/1 入手した市販の樹脂 B〜Gを実施例 Aと同様の方法により加水分解しスチレンマレ イン酸共重合体を得た。加水分解の進行を IRスペクトルにより確認した。それぞれの 仕込み量、収量、収率を表 6に示す。また、それぞれの IRスペクトルを図 5から図 16 に示す。 / Maleic anhydride) Resin B 2800 4500 4400 1/1 Resin C 2800 5000 4800 1/1 Resin D 4300 10000 8800 1/1 Resin E 23000 1 34000 53000 1/1 Resin F 30000 217000 58000 1/1 Resin G 3200 5900 5500 2/1 Commercially available resins B to G were hydrolyzed in the same manner as in Example A to obtain styrene maleic acid copolymers. The progress of hydrolysis was confirmed by IR spectrum. Table 6 shows the charge, yield, and yield of each. Each IR spectrum is shown in Figs.
[表 6] [Table 6]
Figure imgf000026_0001
Figure imgf000026_0001
2.抗菌剤組成物の調製と成膜 2. Preparation and film formation of antibacterial agent composition
下の表 7の実施例 3〜 12、比較例 2及び 3に示された組成の組成物を調製した。 製法は実施例 Aと同様の方法で行 ヽ、実施例 2につ ヽても再度調製した。  Compositions having the compositions shown in Examples 3 to 12 and Comparative Examples 2 and 3 in Table 7 below were prepared. The production method was carried out in the same manner as in Example A, and it was again prepared in Example 2.
[表 7] [Table 7]
各種組成物サンプルとその組成 Various composition samples and their compositions
Figure imgf000027_0001
Figure imgf000027_0001
各実施例及び比較例の残りの組成は水である。  The remaining composition of each example and comparative example is water.
[0073] 実施例 3〜12、実施例 2、比較例 2, 3のサンプルを塩ィ匕ビニル基板 (ァクリサンデ 一社製、透明硬質塩化ビニール板、厚み 0. 5mm、ヘイズ率 1. 0〜1. 3)を用意し、 塩化ビュル基板を地面に垂直に立て 20cm離れたところから市販のスプレーボトルで 塗布した。塗布後室温で 24時間乾燥させて成膜させたものを成膜サンプルとして各 種評価を行った。 [0073] Samples of Examples 3 to 12, Example 2, and Comparative Examples 2 and 3 were prepared from a salty vinyl substrate (manufactured by Akrisande, transparent rigid vinyl chloride plate, thickness 0.5 mm, haze ratio 1.0 to 1). 3) was prepared, and the bull chloride substrate was placed vertically on the ground and applied with a commercially available spray bottle from a distance of 20 cm. Various types of evaluations were performed using samples formed by drying at room temperature for 24 hours after coating, as film formation samples.
[0074] 3.ヘイズ率の測定  [0074] 3. Measurement of haze ratio
上記サンプルにつ!、て、膜の透明性を濁度計(日本電色工業社製)でヘイズ率の 測定を行った結果を表 8に示す。  Table 8 shows the results of measuring the haze ratio of the above samples using a turbidimeter (manufactured by Nippon Denshoku Industries Co., Ltd.).
[表 8] 成膜サンプル名 ヘイズ率 [Table 8] Deposition sample name Haze rate
実施例 2 1. 7 7  Example 2 1. 7 7
実施例 3 1. 8 3  Example 3 1. 8 3
実施例 4 5. 1 3  Example 4 5. 1 3
実施例 5 1. 3 8  Example 5 1. 3 8
実施例 6 2. 64  Example 6 2.64
実施例 7 5. 2 2  Example 7 5. 2 2
実施例 8 4. 8 6  Example 8 4. 8 6
実施例 9 3. 4 1  Example 9 3. 4 1
実施例 1 0 2. 24  Example 1 0 2. 24
実施例 1 1 2. 2 7  Example 1 1 2. 2 7
実施例 1 2 3. 0 6  Example 1 2 3. 0 6
比較例 2 1 5. 4 1  Comparative Example 2 1 5. 4 1
比較例 3 5. 8 0  Comparative Example 3 5. 8 0
4.防カビ試験 4. Mold prevention test
上記方法により得られた成膜サンプルを、 3 X 7.5cmの大きさに裁断して試験片を得 た。シャーレに 20mLのイオン交換水を入れ、そこに試験片を表 9に記載の所定時間 浸漬した。なお加速試験を行うため 2時間おきに試験片を取り出し、イオン交換水を 交換した。浸漬後、室温で 24時間乾燥した。その後、寒天培地上に 3 X 3cmに裁断し たサンプルを置き黒麹カビ胞子懸濁液をスプレー塗布し、試験片の表面の力ビの有 無を 4段階で評価した。  A film sample obtained by the above method was cut into a size of 3 × 7.5 cm to obtain a test piece. 20 mL of ion-exchanged water was put in the petri dish, and the test piece was immersed in the petri dish for a predetermined time described in Table 9. In order to perform an accelerated test, the test piece was taken out every 2 hours and ion-exchanged water was exchanged. After immersion, it was dried at room temperature for 24 hours. Thereafter, a 3 × 3 cm cut sample was placed on an agar medium, and a black mold fungal spore suspension was spray-coated, and the presence or absence of force on the surface of the test piece was evaluated in four stages.
[表 9] [Table 9]
水浸漬時間 Water immersion time
成膜サンプル 0 h 2 h 4 h 6 h 8 h 1 0 1 2 1 8 名 h h h 実施例 2 土 士 土 土 土 + + + + 実施例 3 ― ― ― ― 土 + + 十 + + 実施例 4 ― 士 + + + + + + + + + + + 実施例 5 ― 土 士 士 土 士 土 十十 実施例 6 土 士 士 ± 土 土 十  Deposition sample 0 h 2 h 4 h 6 h 8 h 1 0 1 2 1 8 persons hhh Example 2 Earth Soil Earth Soil + + + + Example 3 ― ― ― ― Sat + + + 10 + + Example 4 ― Example + ― + + + + Example 5 ― Doshi Doji Doji Ten Example 6 Doshi ± Dodo
実施例 8 土 土 士 + + + + + + + 実施例 9 土 土 土 土 士 土 士 土 実施例 1 0 土 土 土 土 士 土 土 士 実施例 1 1 土 土 士 土 + 十 十 +十 実施例 1 2 土 士 士 土 土 士 土 土 比較例 2 ― ― + + + + + + + + 比較例 3 ― 十 + + 十 + + +  Example 8 Earth and Earth + + + + + + + Example 9 Earth and Earth Earth and Earth Soil Earth and Earth Earth Example 1 0 Earth and Earth Earth Earth and Earth Soil Earth and Earth Earth Example 1 1 Earth and Earth Earth Soil Earth + 10 + 10 Example 1 2 Satoshi Satoshi Satoshi Satoshi Comparative Example 2 ― ― + + + + + + + + Comparative Example 3 ― Ten + + Ten + + +
一:カビ無し One: No mold
士:菌糸のみ (実用上問題なし) Shishi: Mycelium only (no problem in practical use)
+ :カビ発生 +: Mold generation
+ + :ブランクと同等のカビ発生  + +: Mold occurrence equivalent to blank
5.榭脂の水への溶解度測定  5. Solubility measurement of rosin in water
各樹脂の水への溶解性を測定した。測定方法は、粉砕した樹脂 lgを 140mLのマ ヨネーズ瓶に量り取りそこへ lOOmLのイオン交換水へ加え水温 25〜30°Cで lhマグ ネチックスターラーで攪拌させた。溶解液を吸引濾過し濾液をエバポレーターで濃縮 し、減圧乾燥後に固形分の量を測定して水への溶解度を算出した。結果を防カビ剤 に使用した際の物性と共に表 10に示す。  The solubility of each resin in water was measured. In the measurement method, pulverized resin lg was weighed into a 140 mL mayonnaise bottle, added to lOOmL ion-exchanged water, and stirred with an lh magnetic stirrer at a water temperature of 25 to 30 ° C. The solution was suction filtered and the filtrate was concentrated with an evaporator. After drying under reduced pressure, the solid content was measured to calculate the solubility in water. The results are shown in Table 10 together with the physical properties when used as an antifungal agent.
[表 10] 使用樹脂 水への溶解度 実施例 塗膜のヘイズ 塗膜の防力ビ [Table 10] Resin used Solubility in water Example Haze of paint film
/p pm 持続性 樹脂 a 109 実施例 2 1. 77 8 h 樹脂 b 1 028 実施例 3 1. 83 8 h 榭脂 c 7000 実施例 4 5. 13 2 h 樹脂 d 452 実施例 5 1. 38 1 2 h 樹脂 e 18 実施例 6 2. 64 1 0 h 榭脂 g 139 実施例 8 4. 86 4 h / p pm Persistent Resin a 109 Example 2 1. 77 8 h Resin b 1 028 Example 3 1. 83 8 h Resin c 7000 Example 4 5. 13 2 h Resin d 452 Example 5 1. 38 1 2 h Resin e 18 Example 6 2. 64 1 0 h Grease g 139 Example 8 4. 86 4 h
― ― 比較例 2 1 5. 41 2 h― ― Comparative example 2 1 5. 41 2 h
― ― 比較例 3 3. 07 <2 h ― ― Comparative example 3 3. 07 <2 h
[0077] 6.実地試験 [0077] 6. Field test
全面にカビの生えて 1、る水性塗料壁面の浴室につ 、て実際の防カビ性能を評価し た。  Molds were grown on the entire surface, and the actual mold-proofing performance was evaluated in bathrooms with water-borne paint walls.
試験場所:水性塗料壁面の浴室 (新潟県)  Test place: Water-based paint wall bathroom (Niigata Prefecture)
試験時期: 2006年 5月より実施  Test period: Conducted from May 2006
全面にカビの発生した水性塗料壁面を次亜塩素酸ナトリウム系カビ取り剤でカビを 除去した。シャワーをかけ 1時間乾燥させた。その後薬剤を以下の 4種類の区画に分 けスプレー塗布した。 1区画の大きさはタテ lmXョコ 0. 5mとした。 3時間乾燥させた 。その後通常通り浴室を使用しカビの発生状況を観察した。結果を表 11に示す。 サンプル No. 1 ブランク…防力ビ剤を塗らずそのまま  Mold was removed from the wall surface of the water-borne paint, which was moldy, with a sodium hypochlorite mold remover. Showered and dried for 1 hour. The drug was then sprayed into the following four compartments. The size of one section is vertical lmX horizontal 0.5m. Dry for 3 hours. After that, using the bathroom as usual, we observed the occurrence of mold. The results are shown in Table 11. Sample No. 1 Blank… As it is, without applying a protective agent
サンプル No. 2 比較例 2  Sample No. 2 Comparative Example 2
サンプル No. 3 実施例 2  Sample No. 3 Example 2
[表 11]  [Table 11]
Figure imgf000030_0001
Figure imgf000030_0001
カビ発生なし  No mold generation
わずかにカビ発生  Slight mold generation
力ビが発生  Force force occurs
[0078] 〔実施例 C〕 1.抗菌剤組成物の調製と成膜 [Example C] 1. Preparation and film formation of antibacterial agent composition
<実施例 13 > <Example 13>
榭脂 a: 0. 2%、 2, 4, 4,—トリクロ口 2,—ノヽイド口キシジフエ-ルエーテル:0. 2 %を水:エタノール = 1: 1の混合液に溶解した。  Fatty resin a: 0.2%, 2, 4, 4, —Trichrome mouth 2, —Noise mouth oxydiphenyl ether: 0.2% was dissolved in a mixture of water: ethanol = 1: 1.
<実施例 14 > <Example 14>
榭脂 a: 0. 2%、 1, 2 べンゾチアゾロン一 3 : 0. 2%を水:エタノール = 1 : 1の混合 液に溶解した。  Cobalt a: 0.2% and 1,2 benzothiazolone 3: 0.2% were dissolved in a mixture of water: ethanol = 1: 1.
ここで、 2, 4, 4,一トリクロロー 2,一ハイド口キシジフエニルエーテル及び 1, 2 べ ンゾチアゾロン 3は、抗細菌 ·抗酵母成分である。  Here, 2, 4, 4, 1-trichloro-2, 1-hydroxydiphenyl ether and 1,2-benzothiazolone 3 are antibacterial and anti-yeast components.
実施例 13及び 14の組成物につ ヽて、実施例 Bと同一方法で成膜した。  The compositions of Examples 13 and 14 were formed by the same method as Example B.
2.ヘイズ率の測定  2. Measurement of haze rate
実施例 Bと同一方法でヘイズ率を測定した。測定結果を表 12に示す。  The haze ratio was measured by the same method as in Example B. Table 12 shows the measurement results.
[表 12] 抗細菌 ·抗酵母成分含有透明膜とヘイズ率
Figure imgf000031_0001
産業上の利用可能性
[Table 12] Antibacterial · Anti-yeast component-containing transparent film and haze ratio
Figure imgf000031_0001
Industrial applicability
本発明の抗菌剤組成物は、刺激性が低ぐ対象に散布した場合の透明性及び透 明性の持続性が高ぐかつ抗菌効果の持続性も高い。  The antibacterial agent composition of the present invention has high transparency and transparency when applied to a subject with low irritation and high antibacterial effect.

Claims

請求の範囲 The scope of the claims
[I] 疎水性部位を有する有機ポリマーと、抗菌成分と、水又はアルコール系溶媒とを含 有することを特徴とする透明膜形成液状抗菌剤組成物。  [I] A transparent film-forming liquid antibacterial composition comprising an organic polymer having a hydrophobic site, an antibacterial component, and water or an alcohol solvent.
[2] 疎水性部位が、非極性基であることを特徴とする請求項 1に記載の透明膜形成液状 抗菌剤組成物。  [2] The transparent film-forming liquid antibacterial composition according to [1], wherein the hydrophobic site is a nonpolar group.
[3] 非極性基力 アルキル基、アルケニル基、フエ-ル基、縮合多環フエニル基、及び鎖 状多環フエニル基力 なる群力 選ばれるいずれか 1種又は 2種以上であることを特 徴とする請求項 2に記載の透明膜形成液状抗菌剤組成物。  [3] Nonpolar basic force A group power consisting of an alkyl group, an alkenyl group, a phenyl group, a condensed polycyclic phenyl group, and a chain polycyclic phenyl group. The transparent film-forming liquid antibacterial agent composition according to claim 2.
[4] 有機ポリマーが、さらに親水性部位を有していることを特徴とする請求項 1〜3のいず れかに記載の透明膜形成液状抗菌剤組成物。 [4] The transparent film-forming liquid antibacterial composition according to any one of claims 1 to 3, wherein the organic polymer further has a hydrophilic portion.
[5] 親水性部位が、極性基であることを特徴とする請求項 4に記載の透明膜形成液状抗 菌剤組成物。 [5] The transparent film-forming liquid antibacterial composition according to claim 4, wherein the hydrophilic part is a polar group.
[6] 極性基が、カルボキシル基、スルホン酸基、スルホアミド基、アミド基、アミノ基、ィミノ 基、ヒドロキシ基、 4級ァミノ基、ォキシァミノ基、ジァゾ -ゥム基、グァ-ジン基、ヒドラ ジン基、リン酸基、ケィ酸基、アルミン酸基、二トリル基、及びチォアルコール基力 な る群力 選ばれるいずれか 1種又は 2種以上であることを特徴とする請求項 5に記載 の透明膜形成液状抗菌剤組成物。  [6] The polar group is a carboxyl group, sulfonic acid group, sulfoamide group, amide group, amino group, imino group, hydroxy group, quaternary amino group, oxiamino group, diazo-um group, guanidine group, hydrazine 6. The group power of a group, a phosphate group, a kainate group, an aluminate group, a nitrile group, and a thioalcohol group, which is selected from one or two or more types. Transparent film-forming liquid antibacterial agent composition.
[7] 有機ポリマーが、親水性部位を有するモノマーと、疎水性部位を有するモノマーとの 共重合ポリマーであることを特徴とする請求項 1〜6のいずれかに記載の透明膜形成 液状抗菌剤組成物。  7. The transparent film-forming liquid antibacterial agent according to any one of claims 1 to 6, wherein the organic polymer is a copolymer of a monomer having a hydrophilic part and a monomer having a hydrophobic part. Composition.
[8] 有機ポリマーが、スチレンマレイン酸共重合体であることを特徴とする請求項 1〜7の 8. The organic polymer according to claim 1, wherein the organic polymer is a styrene maleic acid copolymer.
Vヽずれかに記載の透明膜形成液状抗菌剤組成物。 V The transparent film-forming liquid antibacterial agent composition according to any one of the above.
[9] 形成された透明膜のヘイズ率が 5以下であることを特徴とする請求項 1〜8のいずれ かに記載の透明膜形成液状抗菌剤組成物。 [9] The transparent film-forming liquid antibacterial composition according to any one of [1] to [8], wherein a haze ratio of the formed transparent film is 5 or less.
[10] 抗菌成分が、 20°Cの水 lOOgに対する溶解度が 0. 2g以下であることを特徴とする請 求項 1〜9のいずれかに記載の透明膜形成液状抗菌剤組成物。 [10] The transparent film-forming liquid antibacterial composition according to any one of claims 1 to 9, wherein the antibacterial component has a solubility in water of 20 ° C. in water of lOOg of 0.2 g or less.
[II] 抗菌成分が、防カビ成分であることを特徴とする請求項 1〜10のいずれかに記載の 透明膜形成液状抗菌剤組成物。 [II] The transparent film-forming liquid antibacterial composition according to any one of claims 1 to 10, wherein the antibacterial component is an antifungal component.
[12] 防カビ成分が、チアベンダゾール、 3—ョードー 2—プロパギルブチルカルバメイト、 1 , 2—ベンゾトリァゾリン一 3—オン、ジョードメチル一 p—トリルスルフォン、 2, 3, 5, 6 テトラクロ口一 4— (メチルスルフォ -ル)ピリジン、及び 1— (2— (2, 4—ジクロロフエ- ル)— 2— (2—プロべ-ルォキシ)ェチル)— 1H—イミダゾール (イマザリル)からなる 群力 選ばれる 、ずれか 1種又は 2種以上であることを特徴とする請求項 11に記載 の透明膜形成液状抗菌剤組成物。 [12] Antifungal ingredients are thiabendazole, 3-yodo-2-propargylbutylcarbamate, 1,2-benzotriazoline-1-one, jodomethyl-1-p-tolylsulfone, 2, 3, 5, 6 Group power consisting of 4- (methylsulfo) pyridine and 1- (2- (2, 4-dichlorophenyl) — 2— (2-propyloxy) ethyl) — 1H-imidazole (imazalyl) 12. The transparent film-forming liquid antibacterial composition according to claim 11, wherein the composition is at least one kind or two or more kinds.
[13] 有機ポリマーの水に対する溶解度が 5〜5000ppmであることを特徴とする請求項 1 〜12のいずれかに記載の透明膜形成液状抗菌剤組成物。  [13] The transparent film-forming liquid antibacterial composition according to any one of [1] to [12], wherein the solubility of the organic polymer in water is 5 to 5000 ppm.
[14] アルコール系溶媒力 20〜100重量0 /0の範囲内のエタノールと、 80〜0重量0 /0の範 囲内の水とからなることを特徴とする請求項 1〜13のいずれかに記載の透明膜形成 液状抗菌剤組成物。 [14] and ethanol in a range of alcoholic solvent power of 20 to 100 weight 0/0, to any one of claims 1 to 13, characterized in that it consists of a 80 to 0 weight 0/0 water within range of The transparent film formation liquid antibacterial agent composition of description.
[15] 有機ポリマーと、抗菌成分との重量比力 1 : 50〜50 : 1の範囲内であることを特徴と する請求項 1〜14のいずれかに記載の透明膜形成液状抗菌剤組成物。  [15] The transparent film-forming liquid antibacterial composition according to any one of [1] to [14], wherein the weight specific force between the organic polymer and the antibacterial component is in the range of 1:50 to 50: 1. .
[16] 有機ポリマーが、組成物全量に対して 0. 01〜: LO重量%の範囲内であることを特徴 とする請求項 1〜15のいずれかに記載の透明膜形成液状抗菌剤組成物。 [16] The transparent film-forming liquid antibacterial composition according to any one of [1] to [15], wherein the organic polymer is in the range of 0.01 to LO weight% with respect to the total amount of the composition. .
[17] 抗菌成分が、組成物全量に対して 0. 01〜: LO重量%の範囲内であることを特徴とす る請求項 1〜16のいずれかに記載の透明膜形成液状抗菌剤組成物。 [17] The transparent film-forming liquid antibacterial composition according to any one of [1] to [16], wherein the antibacterial component is in the range of 0.01 to LO weight% with respect to the total amount of the composition. object.
[18] さらに、水溶性金属酸化物及び Z又は両親媒性の金属酸化物ナノ粒子を含有する ことを特徴とする請求項 1〜17のいずれかに記載の透明膜形成液状抗菌剤組成物 [18] The transparent film-forming liquid antibacterial composition according to any one of [1] to [17], further comprising a water-soluble metal oxide and Z or amphiphilic metal oxide nanoparticles.
[19] 両親媒性の金属ナノ粒子が、加水分解性基及び Z又は水酸基を合計で 1以上有す る金属キレートイ匕合物の加水分解生成物であることを特徴とする請求項 18に記載の 透明膜形成液状抗菌剤組成物。 [19] The method according to claim 18, wherein the amphiphilic metal nanoparticles are hydrolysis products of metal chelate compounds having a total of one or more hydrolyzable groups and Z or hydroxyl groups. A transparent film-forming liquid antibacterial agent composition.
[20] 両親媒性の金属酸ィ匕物ナノ粒子力 粒子径 Inn!〜 30nmのナノ粒子であることを特 徴とする請求項 18又は 19に記載の透明膜形成液状抗菌剤組成物。 [20] Amphiphilic metal oxide nanoparticle force Particle size Inn! 20. The transparent film-forming liquid antibacterial composition according to claim 18 or 19, wherein the composition is a nanoparticle of ˜30 nm.
[21] 両親媒性の金属酸ィ匕物ナノ粒子が、酸ィ匕チタンナノ粒子であることを特徴とする請求 項 18〜20のいずれかに記載の透明膜形成液状抗菌剤組成物。 21. The transparent film-forming liquid antibacterial composition according to any one of claims 18 to 20, wherein the amphiphilic metal oxide nanoparticles are acid titanium nanoparticles.
[22] 請求項 1〜21のいずれかに記載の透明膜形成液状抗菌剤組成物を、窓用透明膜 形成液状抗菌剤組成物、台所用透明膜形成液状抗菌剤組成物及び浴室用透明膜 形成液状抗菌剤組成物の!ヽずれかとして使用する方法。 [22] The transparent film-forming liquid antibacterial agent composition according to any one of claims 1 to 21, which is a transparent film for windows Forming liquid antibacterial composition, transparent film forming liquid antibacterial composition for kitchen, and transparent film forming liquid antibacterial composition for bathroom.
請求項 1〜21のいずれかに記載の透明膜形成液状抗菌剤組成物が、容器に収容さ れてなることを特徴とするスプレー型抗菌剤。 A spray-type antibacterial agent, wherein the transparent film-forming liquid antibacterial agent composition according to any one of claims 1 to 21 is contained in a container.
PCT/JP2007/063609 2006-07-07 2007-07-06 Liquid antimicrobial composition capable of forming transparent films WO2008004677A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008523766A JP5121025B2 (en) 2006-07-07 2007-07-06 Transparent film-forming liquid antibacterial agent composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006-187355 2006-07-07
JP2006187355 2006-07-07

Publications (1)

Publication Number Publication Date
WO2008004677A1 true WO2008004677A1 (en) 2008-01-10

Family

ID=38894643

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/063609 WO2008004677A1 (en) 2006-07-07 2007-07-06 Liquid antimicrobial composition capable of forming transparent films

Country Status (2)

Country Link
JP (1) JP5121025B2 (en)
WO (1) WO2008004677A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010275196A (en) * 2009-05-26 2010-12-09 Nippon Soda Co Ltd Transparent film-forming liquid antimicrobial agent composition
WO2011074188A1 (en) * 2009-12-15 2011-06-23 日本曹達株式会社 Transparent film-forming, liquid antimicrobial composition
JP2018538298A (en) * 2015-12-10 2018-12-27 アダマ・マクテシム・リミテッド Polyelectrolyte layer forming block copolymers and compositions and uses thereof
JP2020200299A (en) * 2019-06-10 2020-12-17 三井化学株式会社 Easily-washable sanitary materials or daily necessaries, and method of removing microorganisms
WO2024034649A1 (en) * 2022-08-10 2024-02-15 積水化学工業株式会社 Viral infection inhibitory agent, resin composition, and viral infection inhibitory product

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101961366B1 (en) * 2018-06-25 2019-03-25 (주) 아이나노 Anti-bacterial agent or deodorant composition containing nano gold particles, and product obtained therefrom

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10245305A (en) * 1997-03-05 1998-09-14 Toyobo Co Ltd Antimicrobial composition
JPH10251565A (en) * 1997-03-11 1998-09-22 Kansai Paint Co Ltd Water-based polish for countermeasure against indoor pollution, water-based clear coating material and reduction in indoor pollution using the same
JPH11504629A (en) * 1995-04-24 1999-04-27 ノバファーム リサーチ (オーストラリア) プロプライアタリー リミティッド Biocide surface film
JPH11279540A (en) * 1998-03-27 1999-10-12 Matsushita Electric Ind Co Ltd Antibacterial transparent water-repellent film and its production
JP2000044846A (en) * 1998-05-27 2000-02-15 Sumitomo Chem Co Ltd Antimicrobial and antifungal synthetic resin plate
JP2003104803A (en) * 2001-09-28 2003-04-09 Asahi Denka Kogyo Kk Antibacterial agent for coating material
JP2003136054A (en) * 2001-10-31 2003-05-13 Nippan Kenkyujo Co Ltd Part of water purifier, method for producing the same and the water purifier
JP2003292868A (en) * 2002-04-02 2003-10-15 Sekisui Chem Co Ltd Aqueous alga-proofing or mildew-proofing coating and its applying method

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11504629A (en) * 1995-04-24 1999-04-27 ノバファーム リサーチ (オーストラリア) プロプライアタリー リミティッド Biocide surface film
JPH10245305A (en) * 1997-03-05 1998-09-14 Toyobo Co Ltd Antimicrobial composition
JPH10251565A (en) * 1997-03-11 1998-09-22 Kansai Paint Co Ltd Water-based polish for countermeasure against indoor pollution, water-based clear coating material and reduction in indoor pollution using the same
JPH11279540A (en) * 1998-03-27 1999-10-12 Matsushita Electric Ind Co Ltd Antibacterial transparent water-repellent film and its production
JP2000044846A (en) * 1998-05-27 2000-02-15 Sumitomo Chem Co Ltd Antimicrobial and antifungal synthetic resin plate
JP2003104803A (en) * 2001-09-28 2003-04-09 Asahi Denka Kogyo Kk Antibacterial agent for coating material
JP2003136054A (en) * 2001-10-31 2003-05-13 Nippan Kenkyujo Co Ltd Part of water purifier, method for producing the same and the water purifier
JP2003292868A (en) * 2002-04-02 2003-10-15 Sekisui Chem Co Ltd Aqueous alga-proofing or mildew-proofing coating and its applying method

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010275196A (en) * 2009-05-26 2010-12-09 Nippon Soda Co Ltd Transparent film-forming liquid antimicrobial agent composition
WO2011074188A1 (en) * 2009-12-15 2011-06-23 日本曹達株式会社 Transparent film-forming, liquid antimicrobial composition
CN102655749A (en) * 2009-12-15 2012-09-05 日本曹达株式会社 Transparent film-forming, liquid antimicrobial composition
JPWO2011074188A1 (en) * 2009-12-15 2013-04-25 日本曹達株式会社 Transparent film-forming liquid antibacterial agent composition
JP5550661B2 (en) * 2009-12-15 2014-07-16 日本曹達株式会社 Transparent film-forming liquid antibacterial agent composition
CN102655749B (en) * 2009-12-15 2014-08-27 日本曹达株式会社 Transparent film-forming, liquid antimicrobial composition
JP2018538298A (en) * 2015-12-10 2018-12-27 アダマ・マクテシム・リミテッド Polyelectrolyte layer forming block copolymers and compositions and uses thereof
JP7139246B2 (en) 2015-12-10 2022-09-20 アダマ・マクテシム・リミテッド Polyelectrolyte layering block copolymers and compositions and uses thereof
JP2020200299A (en) * 2019-06-10 2020-12-17 三井化学株式会社 Easily-washable sanitary materials or daily necessaries, and method of removing microorganisms
JP7421281B2 (en) 2019-06-10 2024-01-24 三井化学株式会社 Easy-to-clean sanitary materials or daily necessities and methods for removing microorganisms
WO2024034649A1 (en) * 2022-08-10 2024-02-15 積水化学工業株式会社 Viral infection inhibitory agent, resin composition, and viral infection inhibitory product

Also Published As

Publication number Publication date
JP5121025B2 (en) 2013-01-16
JPWO2008004677A1 (en) 2009-12-10

Similar Documents

Publication Publication Date Title
EP1330501B1 (en) Object having a microbicide coating, method for the production thereof and use of the same
JP6550350B2 (en) Antibacterial liquid, antibacterial film and wet wiper
US7851653B2 (en) Method of creating a solvent-free polymeric silicon-containing quaternary ammonium antimicrobial agent having superior sustained antimicrobial properties
WO2008004677A1 (en) Liquid antimicrobial composition capable of forming transparent films
JP6914715B2 (en) Film
TWI721160B (en) Composition
CN109476932B (en) Antimicrobial coating compositions and related methods
Cheng et al. Fabrication of robust antibacterial coatings based on an organic–inorganic hybrid system
JP6894750B2 (en) Compounds and compositions containing compounds
EP1499692A1 (en) Substrates having a biofilm-inhibiting coating
WO2021248098A1 (en) Graftable biocidal linkers and polymers and uses thereof
JPH0733321B2 (en) Antibacterial silica gel and antibacterial resin
JP2017201005A (en) Composition for application by spraying
Shum et al. UV-curable surface-attached antimicrobial polymeric onium coatings: designing effective, solvent-resistant coatings for plastic surfaces
JP2826274B2 (en) Antibacterial coating composition
EP4081604B1 (en) An omniphobic and biocide sol-gel coating composition
JP5579355B2 (en) Liquid antibacterial composition
JP2014133773A (en) Liquid antimicrobial agent composition
US20140163136A1 (en) Hydrophilic biocidal coatings
JP2000044408A (en) Antibacterial agent, antibacterial resin composition and antibacterial molded product
JPH08165214A (en) Mildewproofing agent for tile joint
JPH0726172A (en) Composition for surface treatment

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07768334

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008523766

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07768334

Country of ref document: EP

Kind code of ref document: A1